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Abstract 
Background 
The prompt seeking of medical care after the onset of symptoms suggestive of 
acute coronary syndromes (ACS)/acute myocardial infarction (AMI) is associated with 
the receipt of coronary reperfusion therapy, and effective cardiac medications in patients 
with an ACS/AMI and is crucial to reducing mortality and the risk of serious clinical 
complications in these patients. Despite declines in important hospital complications and 
short-term death rates in patients hospitalized with an ACS/AMI, several patient groups 
remain at increased risk for these adverse outcomes, including women and the elderly. 
However, recent trends in age and sex differences in extent of pre-hospital delay, hospital 
management practices, and short-term outcomes associated with ACS/AMI remain 
unexplored.  
The objectives of this study were to examine the overall magnitude, and changing 
trends therein, of age and sex differences in duration of pre-hospital delay (1986-2005), 
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hospital management practices (1999-2007), and short-terms outcomes (1975-2005) in 
patients hospitalized with ACS/AMI. 
Methods  
Data from 13,663 residents of the Worcester, MA, metropolitan area hospitalized 
at all greater Worcester medical centers for AMI 15 biennial periods between 1975 and 
2005 (Worcester Heart Attack Study), and from 50,096 patients hospitalized with an ACS 
in 106 medical centers in 14 countries participating in the Global Registry of Acute 
Coronary Events (GRACE) between 2000 and 2007 were used for this investigation. 
Results  
In comparison with men <65 years, patients in other age-sex strata exhibited 
significantly longer pre-hospital delay, with the exception of women < 65 years; had a 
significantly lower odds of receiving aspirin, angiotensin converting enzyme (ACE) 
inhibitors or angiotensin II receptor blockers (ARBs), beta blockers, statins, and 
undergoing coronary artery bypass graft surgery (CABG) surgery or percutaneous 
coronary intervention (PCI), and were significantly more likely to develop atrial 
fibrillation, cardiogenic shock, heart failure, and to die during hospitalization and in the 
first 30 days after admission. There was a significant interaction between age and sex in 
relation to the use of several medications and the development of several of these 
outcomes; in patients <65 years, women were less likely to have received these 
treatments and were more likely to develop these complications and die compared with 
men; in patients ≥ 65 years, however, there were no significant sex differences in these 
outcomes. Age and sex differences in duration of pre-hospital delay have narrowed over 
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time; however, age and sex differences in hospital management practices and short-term 
outcomes have not changed significantly over time.  
Conclusions  
Our results suggest that the elderly were more likely to experience longer pre-
hospital delay, were less likely to be treated with evidence-based treatments during 
hospitalization for acute coronary syndrome, and were more likely to develop adverse 
outcomes compared to younger persons. Younger women were less likely to be treated 
with effective treatments and were more likely to develop adverse outcomes compared 
with younger men while there was no sex difference in these outcomes. Interventions 
targeted at older patients, in particular, are needed to encourage these high-risk patients to 
seek medical care promptly to maximize the benefits of currently available treatment 
modalities. More targeted treatment approaches during hospitalization for ACS/AMI for 
younger women and older patients are needed to improve their hospital prognosis.  
 
Word count: 522 
Key words: Acute myocardial infarction, pre-hospital delay, evidence-based treatment, 
hospital complications, hospital mortality, 30-day mortality, age and sex differences. 
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 CHAPTER I 
Introduction 
1.1 Specific Aims 
The acute coronary syndromes (ACS), an acute manifestation of underlying 
coronary heart disease (CHD), are a major cause of morbidity and mortality throughout 
the world.1 Thrombolytic agents  and other coronary reperfusion therapies are more 
effective in patients with evolving acute coronary disease if patients are treated 
promptly.2-4 Older individuals and women have been shown to be at greater risk for dying 
after acute myocardial infarction than respective comparison groups, suggesting that 
there are differences in disease characteristics, health care seeking behaviors, receipt of 
different treatment strategies, and other factors between men and women of different ages.   
Although several studies have suggested that older patients and women with an acute 
coronary syndrome/ acute myocardial infarction (ACS/AMI) are more likely to present to 
the hospital after prolonged delay, to be less aggressively treated, and to suffer poorer 
outcomes compared to younger patients and men, a limited number of studies have 
examined differences in these outcomes from a long-term, population-based, and/or 
multinational perspective. Moreover, little contemporary research has been conducted 
examining potentially changing differences in these outcomes between men and women 
of varying ages during recent as compared to earlier periods. 
The objectives of my proposed research were to examine age and sex differences 
in extent of pre-hospital delay, receipt of evidence-based medications and cardiac 
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procedures, and short-term outcomes in patients with an ACS/AMI; a secondary study 
goal was to investigate whether differences in these outcomes have changed over time 
between men and women and in patients of various age strata. This was accomplished 
through the secondary analysis of data from two large registries for patients hospitalized 
with ACS/AMI: the Worcester Heart Attack Study (WHAS) and the Global Registry of 
Acute Coronary Events (GRACE). The WHAS is an ongoing population-based 
surveillance study which is examining long-term trends in the clinical epidemiology of 
AMI in  patients hospitalized at all greater Worcester, MA, medical centers in 15 study 
periods between 1975 and 20052,5,6. The GRACE project is a large multinational 
observational study of patients hospitalized with ACS at 106 hospitals in 14 countries in 
North and South America, Europe, Australia and New Zealand over the period 1999-
2007.7,8 
The specific aims and accompanying hypotheses of this proposal were as follows: 
 Aim 1: To examine age and sex differences in duration of pre-hospital delay, defined as 
the time interval from the onset of  acute symptoms suggestive of an AMI  to arrival at 
the hospital’s emergency department, and changing trends, among residents of the 
Worcester metropolitan area  with AMI in the WHAS  over the period 1986-2005. 
Hypothesis:  Older patients and women will exhibit longer pre-hospital delays than 
younger patients and men both crudely and after adjusting for factors that could 
potentially confound these associations; however, these age and sex differences will have 
narrowed over time.  
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Aim 2: To examine age and sex differences in the receipt of evidence-based cardiac 
medications and procedures, and changing trends, during hospitalization in patients with 
an ACS enrolled in the GRACE registry over the period 1999 -2007. 
Hypothesis:  Older patients and women will be less likely to be prescribed evidence-
based cardiac medications and procedures than younger patients and men both crudely 
and after adjusting for factors that could potentially confound these associations; however, 
these age and sex differences will have narrowed over time. 
 Aim 3: To examine age and sex differences in important hospital clinical complications, 
hospital case fatality rates (CFRs), 30-day mortality, and changing trends, in patients with 
an AMI included in the WHAS over the period 1975-2005.  
Hypothesis:  Older patients and women will experience higher complication and death 
rates than younger patients and men both crudely and after adjusting for factors that 
might potentially confound these associations; however, these age and sex differences in 
these endpoints will have narrowed over time. 
1.2 Background and Significance 
 
1.2.1 Scope of the Problem of ACS/AMI 
Coronary heart disease (CHD) is the leading cause of morbidity and mortality in 
men and women throughout the world.1  In 2004, 3.8 million men and 3.4 million women 
worldwide died from CHD.1  Beginning in the early part of the 20th century, death rates 
from CHD in the U.S. increased dramatically reaching epidemic proportions by the mid 
to late 1960's.9-11 Since that time, there have been continuing declines in these death rates , 
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with an approximate 5% average annual decline in the age-adjusted mortality  from CHD 
in the U.S. between 1999 and 2004.12,13 However, CHD continues to be the leading cause 
of mortality in American men and women, claiming almost 450,000 lives in 2005.13 In 
2009, an estimated 1 million Americans will have an AMI and  more than one-quarter of 
these persons will die as a result of this disease.13 Persons with an AMI have a sudden 
death rate 4 to 6 times  higher than that of the general population and upwards of one half 
of patients with AMI will die before reaching the hospital with men were more likely to 
die out of hospital than women.13  
Internationally, inconsistent trends in CHD mortality have occurred since the late 
1960's and into the mid-2000’s.12,13 The death rates from CHD in some countries have 
declined, whereas mortality from CHD has either remained stable or increased in others 
during this period. In 2004, the U.S. ranked 7th highest for CHD mortality in men and 5th 
highest in women in published data from 18 industrialized countries.1,12,13  
1.2.2 Pre-hospital Delay in Patients with an ACS/AMI 
 
 
For persons with an evolving AMI, the prompt administration of coronary 
reperfusion therapy has been shown to reduce mortality and important clinical 
complications in these high risk patients.  Thrombolytics and other coronary reperfusion 
therapies are more effective if patients are treated earlier in their disease course than 
later.2-4 The National Heart Attack Alert Program (NHAAP)14 recommends that 
thrombolytic treatment should be administered  within 30 minutes of hospital arrival, and 
percutaneous coronary intervention (PCI) procedures within two hours of hospital arrival,  
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for maximum benefits. Previous studies have shown that the duration of pre-hospital 
delay is inversely associated with the receipt of hospital reperfusion treatments,  
including  thrombolytic agents and  primary PCI; patients with  longer pre-hospital delay 
are less likely to receive reperfusion treatments compared to those with shorter delay 
times.15,16 However, more than one-half of  patients with AMI delay seeking medical care 
by more than 2 hours,17-19 and more than one-quarter of  patients with AMI delay seeking 
care by more than 6 hours.17-20 
Pre-hospital delay is defined as the time interval from the development of acute 
symptoms suggestive of AMI to arrival at the hospital’s emergency department and 
consists of the following two components: 
1. Decision time or patient delay: The period between the awareness of symptoms 
and the decision to seek treatment; 
2. Transportation time or transportation delay: The period between initiation of 
travel to the emergency room and emergency department arrival. 
While delay can occur at any of these stages, the majority of pre-hospital delay in 
patients with AMI has been attributed to patient indecision in acting on and failure to 
recognize the seriousness of their acute and evolving symptoms suggestive of  AMI.21 
Factor Associated with Duration of Pre-hospital delay 
To effectively reduce pre-hospital delay, the factors that contribute to it must be 
identified. A summary from the National Heart, Lung, and Blood Institute Educational 
Strategies Working Group suggested that clinical presentation (hemodynamic instability, 
large infarction, and sudden onset of severe chest pain), knowledge of the disease 
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(recognition by patients that symptoms are heart related), and  health care  seeking 
behaviors (e.g., consulting friend, co-workers or strangers) were associated with reduced  
pre-hospital delay. On the other hand, socio-demographic characteristics (e.g., older age, 
female, African American, low SES), medical history of  angina or diabetes,  
psychological factors (low emotional/somatic awareness), and other health seeking 
behaviors (consulting spouse and other relative, consulting physicians and self treatment) 
were associated with longer pre-hospital delay.14,22 
Although considerable public health efforts have been made to educate patients 
about the symptoms of AMI, and the importance of seeking health care immediately in 
the setting of possible acute coronary disease, little change in extent of  pre-hospital delay 
has been achieved through current or past efforts.18,23,24 For example, the Rapid Early 
Action for Coronary Treatment (REACT) study, a randomized, controlled community 
trial of 20 U.S. communities pair matched on several demographic characteristics, was 
conducted from 1995-1997 to examine the effects of an extensive community –wide  
intervention on patient delay and emergency medical service (EMS) use in patients with 
acute CHD.25,26 The intervention targeted mass media, community organizations, and 
professional, public, and patient education. Despite the intensive 18-month intervention, 
time from symptom onset to hospital arrival for patients with chest pain did not change 
significantly between intervention and control communities, although increased 
appropriate EMS use was observed in the intervention communities. In addition, a recent 
trial (2000-2006) using a nurse-counseling intervention for patients with documented 
CHD that focused on information, emotional issues, and social factors also failed to 
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reduce pre-hospital delay in 3,500 patients with documented CHD.27 The results of these 
relatively recent trials suggest that our understanding of the reasons for delay in seeking 
care in patients with symptoms suggestive of ACS may be inadequate, as may be our 
educational approaches and intervention efforts, or health care providers are not 
effectively educating the public about the importance of seeking care quickly after the 
onset of acute coronary symptoms. On the other hand, the negative results of several 
published trials may be partially due to inaccurate information on duration of pre-hospital 
delay since data on pre-hospital delay is subject to information bias; patients may fail to 
recognize signs and symptoms suggestive of AMI, accurately recall the time of acute 
symptoms onset, or medical staff may fail to collect accurate and reliable information. 
Age and Sex Differences in Duration of Pre-hospital Delay 
The limited number of studies examining potential age and sex differences in the 
distribution and extent of pre-hospital delay in patients hospitalized with AMI has found 
inconsistent results.8,18,19,23,28-40 Several studies have found that women  are more likely to 
experience longer delay compared to men,23,24,29,41-44  while other studies have suggested 
that there are no differences in duration of pre-hospital delay between men and 
women.17,18,45  In terms of age, most previous studies have suggested that older 
individuals are more likely to report prolonged pre-hospital delay for AMI than younger 
persons.18,23,24,42 However, several studies have failed to find any  association between 
age and extent of pre-hospital delay.28,29,44,46  These discrepant results may due to 
differences in study populations (eg. STEMI vs. NSTEMI; incident AMI vs. prior AMI), 
sample sizes, level of adjustment for potential confounders, and other related factors. 
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Several factors may account for possible age and sex differences in extent of pre-
hospital delay in the setting of evolving acute coronary disease. Compared to younger 
patients and men, older patients and women are more likely to report  atypical symptoms 
of AMI 47-50 and to have additional co-morbidities present,49-51 including diabetes, 
hypertension,  and  heart failure, which may make them misinterpret the symptoms of 
AMI.18-20,35,52  Furthermore, women may lack adequate knowledge of the symptoms of 
AMI or consider heart attack as a “male disease”; therefore, they did not recognize the 
importance of their symptoms in seeking medical care in a more timely fashion.  Women 
have also been shown to be more likely to contact their physician, or self treat their  
symptoms of AMI than men, which likely have contributed to prolonged delay patterns.53 
Women are also more likely to be widowed and living alone at the time of symptom 
onset,39 which has previously been shown to be an independent predictor of prolonged 
delay.29,35  Women have also been reported to be more likely to cope with their illness by 
themselves and did not want to trouble anyone, which has been  found to be associated 
with longer delay times.29,44 
Few contemporary population-based data have examined these associations or 
whether these associations have changed over time. In addition, limited studies have 
examined factors associated with pre-hospital delay according to age and sex; several of 
these studies have had a number of methodological limitations including lack of 
population-based designs and having small sample sizes that likely limited the 
generalizability of their findings. A systematic review including 44 articles (from 42 
studies) which were published between 1960 and 2008 showed that  in the majority of 
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studies examined, women and older persons (≥65 years) were more likely to arrive at the 
hospital later, compared to men and younger persons, among  patients hospitalized with 
AMI.  Several factors associated with pre-hospital delay, including socio-demographic, 
medical history, clinical presentation, psychological and contextual characteristics, also 
differed according to sex.54 
In the proposed study, contemporary trends in age and sex differences in duration 
of pre-hospital delay among persons experiencing an AMI were examined using data 
from the WHAS, a long-term, population-based observational study of patients with AMI.  
1.2.3  Evidence-based Treatments for ACS/AMI 
 
 
The decline in mortality attributed to CHD in the U.S. during the past 4 decades 
has been due in large part to the increasing adoption of new preventive and therapeutic 
strategies, with changes in medical treatment having contributed substantially to these 
declining death rates.          
  Particularly striking changes have taken place in the medical management of 
patients experiencing an AMI during the past 20 years. The effectiveness of aspirin, β-
blockers, and early administration of coronary reperfusion therapy in patients with AMI 
has been well established.55,56 National expert panels have advocated for the routine use 
of aspirin and  β-blockers in patients with a recent AMI and for the long-term use of 
angiotensin converting enzyme (ACE) inhibitors and lipid-lowering therapy.57-63 The 
introduction of ACE inhibitors to clinical practice in the early 1990’s has been shown to 
improve left ventricular function and early survival after AMI.64,65 More recently, 
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primary PCI has been increasingly adopted as the main modality for the timely 
reperfusion of the infarct related coronary artery, in conjunction with the use of several 
adjunctive therapies. Data from the National Registry of Myocardial Infarction, study 
(1995-1999), which included  more than 1.5 million  patients hospitalized with AMI, 
showed increasing  utilization of aspirin, β-blockers, ACE inhibitors and cardiac 
procedures during the first 24 hours of hospitalization over the decade long period under 
study.47,66-68 A review paper of changing trends in  patient management practices in 
patients hospitalized with AMI between 1975-1995 showed encouraging  increases in the  
utilization of  aspirin (5% vs. 75%) and beta blockers (21% vs. 50%) over this period.69 
The American College of Cardiology, the American Heart Association 
(ACC/AHA) and European guidelines for  the hospital management  for patients with ST 
segment elevation MI (STEMI) and patients with non- ST segment elevation MI 
(NSTEMI) /Unstable angina (UA) were published in the 1990s and 2000s. These 
guidelines recommend that evidence –based treatments, including aspirin, β-blockers, 
ACE inhibitors, and lipid lowering agents, should be used for all eligible patients with 
ACS during hospitalization, irrespective of age and sex.62,63 The updated guidelines in 
2007 have reinforced the use of these treatments70,71 and further emphasize that older 
patients and women have the same benefits from these effective treatments as do younger 
patients and men. Even though published clinical evidence does not support withholding 
the most effective cardiac therapies on the basis of age,72,73 elderly patients with an ACS 
are typically  treated less aggressively than younger patients.19,45,74-76 Moreover, despite 
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the greater prevalence of CHD in men,5,77 women with an  ACS are  more likely than 
men  to experience  adverse  in-hospital and post-discharge outcomes.78,79 
Factors Associated with the Use of Evidence-based Treatments in Patients with 
ACS/AMI 
Several studies examining factors associated with the receipt of evidence-based 
medications and procedures among persons with ACS/AMI have found that admission to 
teaching/academic hospitals and treatment by cardiologists are associated with higher 
utilization rates of evidence-based medications and procedures.75 On the other hand, 
being from a lower SES, not having medical  insurance, history of heart failure, diabetes, 
hypertension, kidney disease, PCI, or CABG, prolonged pre-hospital delay, and 
development of hospital complications were  associated with lower rates of utilization of 
evidence-based cardiac medications and interventional procedures.75,80,81 
Age and Sex Differences in the Use of Evidence-based Treatments in Patients with 
ACS/AMI 
Several prior studies have examined possible age and sex differences in cardiac 
medication and procedure use during hospitalization in patients with ACS17,48,51,76,82-86 
with discrepant results. Some studies found that older individuals and women were less 
likely to be treated with evidence–based cardiac medications and procedures, while other 
studies suggested that there were no differences between men and women and among 
patients of different age groups in the utilization of these effective treatments.  These 
conflicting results may be due to differences in study populations (eg., STEMI vs. 
NSTEMI/UA), study period, timing of treatment administration (treatments received in 
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the first 24 hours of hospitalization vs. treatments prescribed at any time during 
hospitalization), sample sizes and level of adjustment for potential confounders.  Age and 
sex differences in the hospital management of patients with ACS may be partially 
explained by differences in the extent of pre-hospital delay between younger and  older 
patients and between men and women.18,52  Older patients and women are also more 
likely to have multiple complex co-morbidities  present, including  heart failure, 
hypertension, and diabetes,17,39,86-88 and  tend to present with more atypical signs and 
symptoms of acute coronary disease than younger patients and men,50,89  which can make 
their diagnosis and management all the more difficult. Furthermore, physicians may not 
believe that the effectiveness of these treatments is as great in the elderly and women or 
they are more likely to have adverse events or complications. Differences in these 
treatment practices may also be due to patients’ preferences or to their health insurance 
status. 
While a  number of studies have examined associations between age and sex and 
the use of evidence-based treatments for ACS in the US26,90 and in Europe,81,86  few 
studies have examined these associations from the broader perspective of a multinational 
investigation. Moreover, little contemporary multinational research has investigated 
changes in age and sex differences in the prescribing of evidence-based therapies in 
patients hospitalized with an ACS and whether previously noted differences in the receipt 
of effective cardiac medications have narrowed over time between men and women and 
among patients of different ages. 
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 In the proposed study, contemporary trends in the utilization of evidence-based 
cardiac medications and interventional procedures according to age and sex were 
examined using data from 14 countries participating in the GRACE study.  
1.2.4 Hospital Complications and Mortality in Patients with an 
ACS/AMI 
Over the past several decades, substantial improvements in pharmacological and 
interventional therapies for ACS/AMI have been accompanied by reductions in in-
hospital complications and in hospital death rates.  According to data from the National 
Registry of Myocardial Infarction (NRMI) , adjusted hospital mortality declined  among 
all  patients by approximately one quarter between 1994 (10.4%) and 2006 (6.3%).91  
In terms of clinical complications after an AMI, including atrial fibrillation (AF), 
heart failure, cardiogenic shock, ventricular fibrillation (VF), stroke, and complete heart 
block, few long-term assessments of contemporary, population-based estimates of the 
magnitude and trends in these important clinical complications according to age and sex 
after an ACS/AMI are available. 
Factors Associated with Declines in Hospital Mortality  
The  factors contributing to the encouraging decline in mortality attributed to 
CHD seen nationally over the past nearly 40 years have not been fully elucidated, and the 
relative contributions of changing trends in the incidence and case-fatality rates of acute 
CHD overall, as well as in men and women of different age strata, remain incompletely 
understood.            
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 Several studies have shown that the use of evidence-based treatments accounted 
for a significant reduction in mortality in patients with CHD. For example, a report from 
the CDC suggested that approximately 47% of this decrease was attributed to the 
increased utilization of effective cardiac treatments, including secondary preventive 
therapies after myocardial infarction or revascularization (11%), initial treatments for 
AMI or unstable angina (10%), treatments for heart failure (9%), revascularization for 
chronic angina (5%), and other therapies (12%). Approximately 44% of the decline in the 
CHD death rate over the period 1980-2000 was attributed to changes in important 
coronary risk factors including reductions in total cholesterol (24%), systolic blood 
pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these 
reductions were partially offset by increases in body-mass index and the prevalence of 
diabetes, which accounted for an increased number of deaths (8% and 10%, 
respectively).92 
 
A review paper examining  trends in outcomes associated with hospitalization for  
AMI estimated that the increase in use of aspirin, beta blockers, ACE inhibitors and 
coronary reperfusion therapy  explained approximately three quarters   of the decrease in 
the 30-day age and sex adjusted mortality rate from 1975-1995.69 This study suggested 
that if other treatments (such as heparin or non-primary angioplasty) are included, up to 
90% of the decrease in 30-day mortality can be explained by changes in treatment 
practices over the past several decades.  
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Age and Sex Differences in Hospital Complications and Mortality 
Previous studies examining age and sex differences in hospital complications and 
deaths in the setting of AMI have demonstrated inconsistent results. Some studies  found 
that older persons had higher rates of hospital complications and deaths compared to 
younger patients51,93 and that women had higher rates of hospital complications and 
mortality  compared  with   men.94,95 On the other hand, several studies failed to find any 
association between age/sex and hospital complications/deaths.81,85,86 For example, data 
from the NRMI-2 showed that,  among patients less than 50 years of age, the mortality 
rate for women was more than twice that for men; however,  these differences decreased 
with advancing age.94 On the other hand, a recent report from the large AMIS Plus 
registry in Switzerland showed that women were, in general,  no more likely to die during 
hospitalization for AMI  than men, within various  age categories and overall.81 There are 
several possible explanations for these discrepant study results including differences in 
patient populations, study period, sample sizes, and the level of adjustment for major 
confounders.  Age and sex differences in hospital outcomes including complications and 
deaths may be partially explained by differences in the extent of pre-hospital delay 
between men and women, and between younger and  older patients.18,52,86  Older patients 
and women are also more likely to have multiple complex co-morbidities  present, 
including  heart failure, hypertension, and diabetes17,39,86-88 that may contribute to their 
higher risk of adverse outcomes compared to younger patients and men. Lastly, older 
patients and women have been shown to be  less likely to be treated with effective cardiac 
medications and procedures compared to younger patients and men.80,90,96 
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Few contemporary population-based studies have  examined whether  differences 
in hospital outcomes  observed in prior studies according to age and sex have changed 
over time or whether these gaps have narrowed between men and women and among 
patients of different age strata.  
In the proposed study, contemporary trends in the occurrence of various hospital 
complications and short-term (in hospital and 30-day) mortality according to age and sex 
were examined using data from the WHAS, a long term, contemporary, population-based 
observational study of greater Worcester (MA) residents hospitalized  with AMI at all 
area medical centers 
1.3 Significance of Proposed Study 
 
In summary, ACS/AMI is a significant and growing public health and clinical 
concern. Despite improving trends in short-term outcomes after an ACS/AMI, important 
gaps between men and women and among individuals of different ages may persist. 
Therefore, there is a need for contemporary epidemiologic research that systematically 
describes differences in extent of patients’ pre-hospital delay, receipt of hospital 
treatments and outcomes, including mortality and complications, according to age and 
sex and to determine whether differences in these endpoints have changed over time. The 
findings of this proposed research will provide useful current information regarding age 
and sex differences in patients hospitalized with an ACS/AMI with regards to duration of 
pre-hospital delay, hospital management practices, and hospital outcomes that can inform 
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the design of appropriate public health interventions and clinical guidelines to improve 
the prognosis of men and women of different ages with ACS/AMI. 
1.4 Research Design and Methods 
This dissertation consists of secondary data analyses of patients enrolled in the 
WHAS and the GRACE project. The purpose of the proposed study was to examine 
differences in the duration of pre-hospital delay, the receipt of evidence-based treatments, 
and in hospital complications and CFRs according to age and sex. A secondary study 
goal is to determine whether differences in these outcomes between men and women and 
among patients of different age strata have changed over time. A particular strength of 
this study is the use of long-term, contemporary data from two large registries of 
ACS/AMI from population-based and multinational perspectives. The WHAS is an 
ongoing population-based surveillance study which is examining long-term trends in the 
clinical epidemiology of AMI among residents of the Worcester metropolitan area  
hospitalized at all greater Worcester, MA, medical centers.2,5 The GRACE project is a 
large multinational observational study of patients hospitalized with ACS at 106 hospitals 
in 14 countries in North and South America, Europe, Australia and New Zealand.7 
1.4.1 Study Designs, Participating Hospitals, and Patient Populations  
1.4.1.1 The Worcester Heart Attack Study (WHAS) 
The WHAS is an ongoing population-based investigation that is describing long-
term trends in the clinical epidemiology of AMI among residents of the Worcester, MA, 
metropolitan area hospitalized at all 16 greater Worcester (MA) medical centers2,5.  
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Fewer hospitals (n=11) have been included during recent study years due to hospital 
closures, mergers, or conversion to chronic care facilities. Data have been collected in 
this observational study on an approximate biennial basis since the initial study year of 
1975, and continuing to the most recent year of investigation in 2005, which presently 
includes a total of 15 cohorts. The study years were originally selected due to funding 
availability and for purposes of examining changing trends in the principal study 
outcomes on an approximate alternating yearly basis. The city of Worcester is the second 
largest city in MA and is centrally located in New England. The Worcester SMSA is 
characterized by a diverse urban/suburban population whose demographic and 
socioeconomic characteristics are similar to national estimates. These socio-demographic 
characteristics, with the exception of race, reinforce the potential generalizability of 
findings from this stable population base, where outmigration rates remain extremely low. 
Methods of Ascertainment for Newly Diagnosed Cases of AMI  
Computerized printouts of primary as well as secondary discharge diagnoses of 
AMI and related acute and chronic coronary disease rubrics were obtained from all 
participating greater Worcester hospitals for the purpose of identifying newly diagnosed 
cases of AMI occurring during the study periods. The acute care general hospitals 
included 2 in the city of Worcester (UMass Memorial Health Care and St. 
Vincent/Worcester Medical Center), and 9 hospitals in the Worcester metropolitan area 
(Clinton, Harrington Memorial, Health Alliance, Henry Heywood, Hubbard, Marlboro, 
Metrowest, Milford-Regional and Wing). Once the computerized discharge diagnosis 
printouts were obtained from all greater Worcester hospitals, the appropriate (9th and/or 
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10th) International Classification of Disease (ICD) codes for CHD were reviewed by the 
PI and the project director for purposes of sample selection. The 9th revision ICD codes 
included codes 410-414 and 786.5 and the corresponding 10th revision codes of I20-I25 
and R07. The vast majority of validated cases of AMI came from ICD-9 diagnostic rubric 
410 (AMI), followed by a small number of cases from ICD rubric 411 (other acute and 
subacute forms of CHD). An extremely low yield of cases of definite AMI have come 
from ICD rubrics 412 (old MI), 413 (angina pectoris), 414 (other forms of chronic CHD), 
and 786.5 (chest pain); these latter disease categories primarily included patients with 
chronic manifestations of CHD or nonspecific chest pain.   
Diagnostic Criteria for AMI and Study Inclusion/Exclusion criteria: 
Cases of possible AMI treated at all greater Worcester medical centers selected 
were validated according to predefined criteria of AMI. The diagnosis of AMI was made 
on the basis of the well accepted criteria developed by the World Health Organization 
which includes clinical history, serum enzyme, and serial electrocardiographic findings, 
which  has been utilized in a number of clinical and epidemiological investigations 
including the MONICA study.97 These diagnostic criteria consist of: 
 A typical history of prolonged chest pain suggestive of AMI that is not relieved by 
rest and/or use of nitrates 
 Enzyme level elevations of CK and/or its isoenzyme subfraction (CK - MB) 
 Serial ECG changes consistent with the presence of an evolving MI. 
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Patients who satisfied at least 2 of these 3 criteria, and were residents of the 
Worcester metropolitan area, since the study is population-based, were included in this 
study. Patients who developed AMI secondary to an interventional procedure or surgery 
were excluded from the study sample. 
Data Collected from the Review of Hospital Medical Records 
For each patient satisfying the diagnostic and geographic eligibility criteria, socio-
demographic, medical history, and clinical data were abstracted from the medical records 
by trained study physicians and nurses. Information was collected about patient's age, sex, 
race, body mass index (height and weight), pre-hospital delay, comorbidities (e.g., angina, 
diabetes, hypertension, heart failure, stroke), AMI order (initial vs. prior), type (Q wave 
vs. non–Q wave), and location (anterior vs. inferior/posterior), receipt of hospital 
medications and coronary interventional procedures, the occurrence of clinically 
significant in-hospital complications including stroke, heart failure, atrial fibrillation, and 
cardiogenic shock, and hospital discharge status.  
Characteristics of the WHAS Population over Time 
Table 1.1 describes changes in the WHAS population over time. There have been 
relatively dramatic increases in the age profile of greater Worcester residents hospitalized 
with AMI as well as in the proportion of women. There has been a smaller proportion of 
patients presenting to WHAS with a history of angina, but a greater proportion of patients 
presenting with previously diagnosed diabetes, heart failure, MI and stroke.  The 
increasing age and prevalence of serious comorbidities in patients currently hospitalized 
with AMI present significant challenges for the management of these complex high risk 
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patients. In term of clinical complications, the proportion of patients developing AF has 
increased, but the proportions of patients developing heart failure, shock and stroke have 
remained relatively unchanged. In-hospital mortality rates have declined appreciably over 
time, despite the presence of an increasingly older patient population with a greater 
prevalence of comorbidities. The duration of pre-hospital delay has remained unchanged 
over time but length of stay has declined significantly over time. 
Table 1.1 Characteristics of the Worcester Heart Attack Study (WHAS) Population 
Over Time 
Characteristics 1975/1978 
(n=1,626) 
1990/1991 
(n=1,614) 
2003/2005 
(n=2,060) 
Age (median, yrs) 66.0 70.0 74.0 
Male (%) 62.1 57.6 54.3 
Medical history (%)     
      Angina 24.5 27.3 18.7 
      Diabetes  22.1 26.6 34.4 
      Heart failure  13.8 16.8 25.9 
      MI 32.6 31.8 34.8 
      Stroke 5.4 9.2 12.0 
Clinical complications (%)    
     Atrial fibrillation 14.1 17.9 22.5 
     Heart failure 40.5 40.7 39.6 
     Stroke NA 0.5 0.7 
     Shock 7.2 6.1 4.7 
Hospital mortality (CFRs) (%) 20.8 14.8 9.1 
Median (mean) of pre-hospital 
delay, hours 
NA 2 (3) 2(4) 
Mean of  length of stay, days 18.4 15.6 5.2 
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1.4.1.2  Global Registry of Acute Coronary Events Project (GRACE) 
The GRACE study is a large, multinational, observational study of patients 
hospitalized with ACS in 14 countries in North and South America, Europe, Australia, 
and New Zealand between 1999 and 2008. The objectives of GRACE are to improve the 
hospital and long-term outcomes of patients with ACS7. 
Participating Centers and Sampling Methods 
Study hospitals were located in 18 cluster sites of 14 countries. Data collection 
activities began in April 1999 with the goal of collecting data on approximately 10,000 
patients hospitalized with ACS on an annual basis. A total of four sites were included in 
the United States (Massachusetts, Michigan, North Carolina, and California), whereas an 
additional 16 sites were included from Canada, Europe, Australia, and New Zealand. The 
two geographic clusters in South America have recruited relatively more study hospitals 
than other clusters to provide a more descriptive overview of national practices in the 
management and outcomes of patients with ACS. 
These geographic clusters were chosen to represent populations with varying 
demographic, clinical, and treatment characteristics as well as hospital systems of 
different sizes and treatment and diagnostic capabilities. A total of 46 hospitals were 
included at these population sites, representing hospitals of varying size, characteristics, 
and diagnostic and treatment capabilities. At the study clusters in which a population-
based site (where ACS patients from geographically defined catchment areas) was 
considered either not feasible or not cost effective, a sample of hospitals representative of 
those from that region or country was selected and cases of ACS were included 
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irrespective of the patient’s geographic origin. A total of 47 hospitals were included at 
these study clusters. Where required, hospitals received approval from their local 
hospital’s ethics or institutional review board, and signed, informed consent for follow-up 
contact was obtained from the patients at enrollment. For those sites using active 
surveillance for case identification, verbal or written consent was obtained from patients 
to review information contained in their medical charts. 
Patients who died early during their index hospitalization were thereby excluded 
from study consideration at the sites where active case ascertainment was carried out. The 
impact of this and other exclusionary factors needed to be considered in interpreting 
hospital outcomes and the descriptive characteristics and treatment practices used in the 
respective study samples. 
Patient Identification Approaches 
To facilitate the review of medical records in a systematic manner, and 
accommodate the varying ways in which the data were collected, prospective (“warm” or 
active pursuit) and retrospective (“cold” or passive pursuit) surveillance approaches for 
identifying cases of ACS, similar to the MONICA Project97 were adopted. In hospitals 
that used warm pursuit, eligible patients were identified during the index admission and 
medical records were reviewed on an ongoing basis after appropriate consent has been 
obtained, if necessary. In study sites that used the cold pursuit method of approach to 
case identification, hospital listings of persons discharged from participating hospitals 
were reviewed to identify potentially eligible cases with use of the International 
Classification of Diseases, Ninth Revision (ICD-9), codes 410 or 411 or corresponding 
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codes in ICD-10. These charts were subsequently reviewed after the patient has been 
discharged from the hospital. The majority of study centers adopted warm pursuit 
whereas a limited number of centers used cold pursuit to identify cases of ACS. 
Patients hospitalized with a discharge diagnosis of ACS constitute the primary 
sample of interest at the clusters where passive or cold pursuit surveillance was adopted. 
At the centers where warm pursuit surveillance approaches were used, patients with an 
admission diagnosis of ACS were studied irrespective of whether their final discharge 
diagnosis is ACS, another cardiac diagnosis, or non-cardiac disease. The medical records 
of patients with a primary or secondary discharge diagnosis of AMI (ICD-9 code 410) or 
unstable angina (ICD-9 code 411) were reviewed in their entirety at the study sites using 
passive surveillance. Previous surveillance studies have shown a relatively low yield of 
confirmed cases of ACS, particularly AMI, from other possible coronary disease 
diagnostic categories (eg, ICD-9 codes 412-414, 786.5). Thus, the medical records of 
patients with a discharge diagnosis of these latter diagnostic codes were not reviewed. As 
previously mentioned, at the study sites where active or warm pursuit surveillance was 
used, hospitalized patients with a suspected diagnosis of ACS were identified on a regular 
basis and charts were concurrently reviewed. Given the varying sizes of the populations 
under study and the number of patients hospitalized with a suspected or a discharge 
diagnosis of ACS, a sampling scheme was used to select possible cases of ACS for 
subsequent review. Each study site selected a final annual sample of approximately 600 
cases of ACS from each study cluster spread out over the entire year. 
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GRACE inclusion/Exclusion criteria 
 Must have one of the ACS as a presumptive diagnosis. 
 Must be ≥18 years old. 
 Must be alive at the time of hospital presentation. 
 The qualifying ACS must not have been precipitated or accompanied by a significant 
comorbidity such as a motor vehicle crash, trauma, severe gastrointestinal bleeding, 
operation, or procedure. In-patients who were already hospitalized, for any reason, 
when ACS symptoms develop were not eligible for enrollment. 
 Patients transferred into or out of a registry hospital could be enrolled regardless of 
the time spent at the transferring hospital. 
 For patients transferred out of a registry hospital, data collection for the initial case 
report form ended with the transfer and indication of purpose of transfer. 
 Patients could be re-enrolled in GRACE provided that 6 months or more passed since 
the prior enrollment. When a patient was re-enrolled, a new patient number must be 
assigned. 
 The criteria for ACS must be met, with one exception: patients hospitalized for <1 
day who died and did not meet the criteria could be enrolled provided that the cause 
of death was confirmed to be due to ACS. 
Data Abstraction 
A standardized data abstraction form was developed for study-wide use. The team 
of investigators developed the initial case report form, which was subsequently finalized 
for field use after pilot testing at each of the participating hospitals. Information was 
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collected on patient demographic characteristics, medical history, duration of pre-hospital 
delay from the time of onset of acute symptoms to seeking medical care, presenting 
symptoms, electrocardiographic findings, clinical characteristics, use of cardiac 
medications and interventional procedures, and hospital-associated outcomes. 
Standardized definitions for patient-related variables and clinical diagnoses were used. 
All cases of confirmed ACS were assigned to 1 of the following categories: ST-segment 
elevation myocardial infarction (STEMI), non–ST-segment elevation myocardial 
infarction (NSTEMI), or unstable angina (UA). Patients were diagnosed with STEMI 
when they had new or presumed new ST-segment elevation 1 mm seen in any location, 
or new left bundle branch block on the index or subsequent electrocardiogram with at 
least one positive cardiac biochemical marker of necrosis (including troponin 
measurements, whether qualitative or quantitative). In cases of NSTEMI, at least one 
positive cardiac biochemical marker of necrosis without new ST-segment elevation seen 
on the index or subsequent electrocardiogram had to be present. Unstable angina was 
diagnosed when serum biochemical markers indicative of myocardial necrosis in each 
hospital’s laboratory were within the normal range. Full definitions can be found on the 
GRACE web site at www.outcomes.org/grace 
Characteristics of the GRACE Population Over Time 
Table 1.2 presents changing characteristics of the GRACE population over time. 
The mean age and sex distribution of study sample have been unchanged over time. 
There has been a lower proportion of patients presenting to GRACE hospitals with a 
history of angina, heart failure and renal disease, but a greater proportion of patients 
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presenting with a history of diabetes.  The proportion of patients presenting with a history 
of MI and stroke have unchanged. In term of clinical complications and death, the 
proportions of patients developing clinical complications and dying during 
hospitalization have declined over time. Pre-hospital delay (median) has remained 
unchanged whereas the length of hospital stay has declined in the most recent study years. 
Table 1.2 Characteristics of the  Global Registry of Acute Coronary Events (GRACE) 
Population Over Time 
Characteristic 1999/2001 
(n=16,951) 
2002/03 
(n=13,417) 
2004/2005 
(n=11,726) 
2006/2007 
(n=8,002) 
Age (median, yrs) 67.0 66.9 67.4 66.7 
Male (%) 66.0 66.4 66.7 67.4 
Medical history (%)     
      Angina 63.6 51.6 46.7 45.4 
      Diabetes 24.3 24.9 25.5 25.7 
      Heart failure 11.6 10.9 10.5 9.5 
      MI 31.0 30.1 30.7 31.7 
      Renal disease 8.1 7.1 8.1 7.8 
      Stroke 8.7 8.5 8.5 8.4 
Clinical complications (%)     
     Atrial fibrillation 9.1 8.4 7.2 6.4 
     Heart failure 17.2 13.7 10.7 9.3 
     Stroke 0.9 0.7 0.7 0.5 
     Shock 4.6 3.9 3.9 3.7 
Hospital mortality (CFRs) (%) 6.0 5.7 5.0 4.6 
Median (mean) of pre-hospital 
delay, hours 
3 (76) 3 (94) 3 (24) 
3 (31) 
Mean of Length of stay, days 8.2 7.4 6.9 6.8 
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1.4.2 Measures 
1.4.2.1 Aim 1: Association between age/sex and duration of pre-hospital 
delay: WHAS 1986-2005 
Age was categorized into 3 strata: <65 years, 65-74 years, and ≥75 years. Age 
(categorized as 3 groups) and sex were the main independent variables. Duration of pre-
hospital delay, which was defined as the time interval from the onset of symptoms 
suggestive of AMI to hospital arrival, was the main outcome. First, pre-hospital delay 
was modeled as a continuous variable. Second, duration of pre-hospital delay was 
categorized into 3 categories: 0-1.9; 2-5.9, and ≥6 hours to distinguish early from late 
responders to their symptoms of AMI based on the distribution of delay times in the 
present study sample and on findings from the previously published literature.  
Candidate variables considered as potential confounders were chosen based on 
findings from prior studies.  These potential confounding variables  included  study year, 
race (white vs. non-white), marital status (single, married, divorced, widowed),medical  
insurance (private vs. others), comorbidities (e.g., angina, diabetes, hypertension, stroke, 
PCI, CABG), AMI order (initial vs. prior), type (Q wave vs. non–Q wave) and location 
(anterior vs. other), type of AMI (NSTEMI or STEMI), and acute symptoms (chest pain, 
sweating, shortness of breath, nausea, left hand pain and others), time of acute symptoms 
onset (time of day and day of week), and do not resuscitate order (DNR) status. 
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1.4.2.2 Aim 2: Association between age/sex and hospital treatment 
practices: GRACE 1999-2008 
Age was categorized into four strata: <65 years, 65-74 years, 75-84 years, and 
≥85 years. Age (categorized as 4 groups) and sex were the main independent variables. 
The uses of single cardiac medications including aspirin, beta blockers, ACE 
inhibitors/ARBs, statins and the receipt of either PCI or CABG during hospitalization of 
patients with an ACS were the main outcomes for this analysis. Receipt of these 
treatments was assessed individually (yes/no). In addition, the use of multiple 
medications (3 or more and all 4 medications) (yes/no) was also assessed. 
Candidate variables considered as potential confounders were chosen based on 
findings from prior studies. Potential confounding variables included study year, 
geographic region(Australia/NewZealand/Canada, Europe, South America and US),  type 
of hospital (teaching vs. other), admission diagnoses (STEMI vs.  NSTEMI/UA),  
medical history (eg, heart failure, hypertension, diabetes), DNR status  and factors in  the 
GRACE in-hospital risk model (systolic blood pressure, initial serum creatinine findings, 
heart rate, cardiac enzyme, Killip class, ST-segment deviation, and  cardiac arrest at the 
time of hospital arrival for an ACS).98 
1.4.2.3 Aim 3: Association between age/sex and hospital clinical 
complications, hospital mortality (CFRs), and 30-day mortality: 
WHAS 1975-2005 
The key independent variables of age (3 groups: <65 years, 65-74 years, ≥ 75 
years) and sex have been previously defined. The hospital CFRs of patients with AMI 
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was the main outcome for this analysis. Information on hospital CFRs was collected 
through the review of hospital charts. The development of important clinical 
complications during hospitalization of patients with AMI was the secondary outcome 
including stroke, atrial fibrillation (AF), heart failure and cardiogenic shock. The 
occurrence of acute stroke is defined as the development of neurologic changes consistent 
with the presence of a stroke based on information contained in medical records and 
reviewed by a team of nurse and physician abstractors.99  The criteria for AF include the 
documentation of AF in the physicians’ progress notes, based on the review of hospital 
medical records,  or occurrence of typical electrocardiographic changes consistent with a 
diagnosis of AF.100 Heart failure is defined when there is clinical or radiographic 
evidence of pulmonary edema or bilateral basilar rales with an S3 gallop.101 Cardiogenic 
shock is defined as a systolic blood pressure of less than 80 mm Hg in the absence of 
hypovolemia and associated with cyanosis, cold extremities, changes in mental status, 
persistent oliguria, or congestive heart failure.102  
Additional secondary outcome was 30-day mortality. Patients with a validated 
diagnosis of AMI discharged from all Worcester SMSA hospitals have been followed on 
an annual basis through the review of records for additional hospitalizations, search of 
death certificates at state and local Divisions of Vital Statistics, and through use of the 
National Death Index. At the time of the present proposal, some form of additional 
follow-up has been obtained for more than 99% of discharged hospital survivors from the 
cohorts included to date with follow-up completed through 2007. 
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Candidate variables considered to be potential confounders were chosen based on 
findings from prior studies. Potential confounding variables included study year, 
demographic characteristics, medical history, clinical presentation, characteristics of AMI 
and hospital treatments. Demographic variables include race (white vs. non-white), 
marital status (single, married, divorced, widowed), insurance (private vs. others). Co-
morbidities include history of angina, diabetes, hypertension, stroke, heart failure, and MI. 
Information on clinical presentation included pre-hospital delay, acute symptoms, and 
information on DNR status.   Characteristics of AMI included AMI order (initial vs. 
prior), type (Q wave vs. non–Q wave) and location (anterior vs. other), type of AMI 
(NSTEMI or STEMI). Information on hospital treatment approaches (aspirin, ACE 
inhibitors, beta blockers, lipid agents, PCI, CABG, pacing and others) and length of stay 
were also collected.  
1.4.3 Statistical Analysis 
1.4.3.1 Descriptive Analysis and Graphical Analysis of Associations  
The distribution of all independent and dependent variables was examined. This 
was primarily done  to determine the appropriateness of model distributional assumptions 
for dependent variables (outcomes)  and variability of independent variables 
(exposures/predictors) to assess the informational content as well as the choice to 
categorize a value or not.  If the assumptions of normality were not met, transformation 
of the data was considered before categorizing outcomes or using non-parametric 
methods. Transformation was also guided by interpretability issues. In all model building 
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described below, a careful examination was made of the functional association of 
variables. Lowess curves guided our examination and testing of linear vs. non-linear 
associations. The preference was to find simple polynomial curves if a linear association 
was not appropriate. Most models described below were used notation of simple linear 
association but more complex functional associations were possible if not likely.  
1.4.3.2 Analysis for Study Aims 1-3:  
In general, similar analytic approaches (univariate followed by multivariable 
modeling) were carried out to examine the three aims of the proposed study.  
Aim 1: Association between age/sex and duration of pre-hospital delay 
The possible association between age/sex and extent of pre-hospital delay was 
examined using two approaches. In the first approach, a median regression model was 
used to examine the association between age/sex with duration of pre-hospital delay 
(hours), taking into account the skewed distribution of pre-hospital delay.  In addition, 
both multinomial logistic and ordered logistic regression models were created to 
determine the association of age/sex with our principal study outcome expressed as an 
ordinal variable (e.g., pre-hospital delay 0-1.9, 2-5.9, and ≥ 6 hours).  
In each analysis, a series of regression models were used to examine the impact of 
demographic characteristics, comorbidities, and clinical presentation on the association 
between age/sex and pre-hospital delay. The first model included only age, sex, and study 
year. Model 2 further adjusted for other demographic factors and medical history of 
various cardiovascular diseases and comorbidities. Model 3 was further adjusted for AMI 
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associated characteristics and acute presenting symptoms (see footnotes to each table for 
the list of controlling variables). To assess whether any age or sex differences in extent of 
pre-hospital delay have changed over time, 2-way and 3-way interaction terms between 
age, sex, and study year were created and included in each regression model. The 
evidence supporting an association between decreased pre-hospital delay and improved 
short-term outcomes is strongest in patients with STEMI; therefore we repeated all 
analyses in this patient subgroup.  
Since 42% of the study sample had information missing from hospital records on 
extent of pre-hospital delay, we conducted a sensitivity analysis using a propensity-
weighted method to assess whether the missing data influenced our primary study results.  
Other modeling approaches included forward selection and backward elimination 
were considered and compared. Furthermore, since there may be clustered data (patients 
grouped by participating hospitals or regions), random effect models (random intercept 
and random slopes) were considered and compared. 
Model equation:  
Log_delay=β0+β1-3age group1-3+β4sex+ β5-n(confounders)+ βn-m interaction terms + εi    
 εi ~N(0,δ) 
Aim 2: Association between age/sex and the use of cardiac medications and 
interventional procedures 
Logistic regression models were used to determine the overall associations 
between age/sex and the use of single evidence-based cardiac medications (eg, aspirin, 
beta blockers, ACE inhibitors/ARBs, and statins), the utilization of either PCI or CABG 
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procedures, and the receipt of multiple medications (≥ 3 medications) during the patient’s 
index hospitalization as well as in examining changing trends over time. Similar 
univariate analyses followed by multivariable regression modeling as described 
previously in aim 1 were performed. The analyses were performed among all eligible 
patients as well as in subgroups according to type of ACS (STEMI and NSTEMI/UA). 
Model equation:  
logit(p)= β0+β1-4age group1-4+β5sex + β6-n(confounders)+ βn-minteraction terms 
 
Aim 3: Association between age/sex and short-term outcomes 
Logistic regression models were used to determine the association between 
age/sex and hospital complications and mortality outcomes (CFRs) and changing trends 
over time. Similar univariate analyses followed by multivariable regression modeling as 
described previously in aim 1 were applied. For 30-day mortality outcome, the Cox 
Proportional Hazards (PH) models were used to examine unadjusted and adjusted 
associations between age/sex and this outcome. Proportional Hazards assumption was 
checked graphically. A similar multiple regression approach described previously in aim 
1 was applied.  
Model equation:  
log[h(t)/h0(t)] = β1-3age group1-3+β4sex+ β5-n(confounders)+ βn-minteraction terms. 
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1.4.4 Power Calculation 
 
Aim1: The analysis in aim 1 included approximately 6,000 patients with AMI from 1986-
2005.  We used estimations for means of duration of pre-hospital delay and theirs 
standard deviations (SDs) for men and women and patients in different age groups from 
the NRMI study.52  With an available sample size of approximately 6000 patients with 
AMI, we had power of greater  than 90% to detect estimated differences in means of 
duration of pre-hospital delay between men and women and in patients of different age 
groups at α level of 0.05 (Table 1.3). 
 
 
 
 
 
 
Table 1.3 Power Calculation for Hypothesis in Aim 1 
Patient groups 
 
n Estimated mean of pre-
hospital delay (mins) 
SD  
(mins) 
Power 
age <65 yrs (reference) 2,160 107 0.3  
65-74 yrs 1,560 117 0.4 >90% 
≥75 yrs 2,280 126 0.5 >90% 
Men (reference) 3,600 114 0.2  
Women 2,400 125 0.4 >90% 
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Aim2: The analysis in aim 2 included approximately 50,000 patients with ACS from 
1999 to 2007.  We used estimations of proportions of the use of single cardiac  treatments 
for men and women and patients in different age groups from the NRMI study.83 With 
this sample, we had power of more than 80% to detect estimated differences of 2-4% in 
proportions of the uses of single treatment approaches (range: 60%-90% in this 
population) during hospitalization between men and women and in patients of different 
age groups at α level of 0.05 (Table 1.4). 
 
 
 
 
 
Table 1.4 Power Calculation for Hypothesis in Aim 2 
Patient groups n Difference in hospital 
treatment 
Power 
Age <65 yrs (reference) 22,500 0%  
65-74 yrs 13,000 2% >80% 
≥75-84 yrs 10,500 3% >80% 
85 yrs 4,000 4% >80% 
Men (reference) 33,000 0%  
Women 17,000 3% >80% 
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Aim3: The analysis in aim 3 included 13,000 AMI patients from 1975 to 2005. We used 
estimations of in-hospital CFRs for men and women and patients in different age groups 
from the NRMI.103 With this sample, we had power of greater  than 80% to detect 
differences of 2 % in proportions of in hospital CFRs between men and women, and 4-
12% differences in hospital mortality in patients of different age groups at α level of 0.05 
(Table 1.5). 
 
This study has been reviewed and approved by University of Massachusetts 
Medical School IRB. 
 
 
Table 1.5. Power Calculation for Hypothesis in Aim 3 
Patient groups n Difference in hospital CFRs Power 
Age <65 yrs (reference) 4,680 0  
65-74 yrs 3,380 4% (8% vs. 4%) >90% 
≥75yrs 4,940 8% (12% vs. 4%) >90% 
Men (reference) 7,800 0  
Women  5,200 2% (18% vs. 16%) >80% 
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Abstract 
Background 
The prompt administration of coronary reperfusion therapy for patients with an 
evolving acute myocardial infarction (AMI) is crucial in reducing mortality and the risk 
of serious clinical complications in these patients. However, long-term trends in extent of 
pre-hospital delay, and factors affecting patient’s care seeking behavior, remain relatively 
unexplored, especially in men and women of different ages. The objectives of this study 
were to examine the overall magnitude, and 20 year trends (1986-2005), in duration of 
pre-hospital delay in middle-aged and elderly men and women hospitalized with AMI. 
Methods  
The study sample consisted of 5, 967 residents of the Worcester, MA, 
metropolitan area hospitalized at all greater Worcester medical centers for AMI between 
1986 and 2005, who had information available about duration of pre-hospital delay.  
Results 
Compared with men <65 years, patients in other age-sex strata exhibited longer 
pre-hospital delays over the 20-year period under study. The multivariable adjusted 
medians of pre-hospital delay were 1.96, 2.07, and 2.57 hours for men <65 years,  men 65 
-74 years, and men ≥75 years, and 2.08,  2.33, and 2.27  hours for women <65 years, 
women 65-74 years, and  women ≥75 years, respectively. These age and sex differences 
have narrowed over time which has been largely explained by changes in patient’s 
comorbidity profile and AMI associated characteristics.  
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Conclusions  
Our results suggest that community-based educational interventions remain 
needed to encourage patients to seek medical care promptly after the development of 
symptoms suggestive of AMI to maximize the benefits of currently available treatment 
modalities. 
 
Word count: 249 
Key words: Pre-hospital Delay, Acute Myocardial Infarction, Age and Sex differences. 
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2.1  Introduction 
 
The prompt administration of reperfusion therapy to patients with an evolving 
acute myocardial infarction (AMI) can be crucial to reducing mortality and serious 
complications in these patients.  Results from prior studies have shown that reperfusion 
treatment is most effective if patients with ST-segment elevation myocardial infarction 
are treated promptly, particularly within one hour of acute symptom onset.3,4  Although 
an association between extent of pre-hospital delay  and outcomes after  non-ST-segment 
elevation myocardial infarction has not been firmly established, it is assumed that earlier 
evaluation and management of these patients  would be preferable.   
 Despite the importance of seeking medical care as soon as possible after the onset 
of acute coronary symptoms, upwards of one half of patients with AMI delay seeking 
medical care by more than 2 hours, 17,19 and upwards of one quarter of  patients with AMI 
delay seeking care by more than 6 hours. 17,19,20  Several previous studies have also 
suggested  that extent of pre-hospital delay is associated with delays in the receipt of 
effective hospital therapies,19,104 primarily coronary reperfusion therapy.  
Although considerable efforts have been expended to educate patients about the  
symptoms of AMI, and the importance of seeking  medical care promptly,  the care 
seeking behavior of  patients  hospitalized with AMI has not changed appreciably.18,23,24  
The Rapid Early Action for Coronary Treatment (REACT) trial, a randomized, controlled 
trial of 20 pair-matched U.S. communities, was designed to examine the effects of a  
community–wide  intervention on patient delay and emergency medical service use in 
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patients with acute coronary disease.25,26 The intervention targeted the mass media, 
community organizations,  and professional, public,  and patient education. Despite the 
intensive 18-month long intervention, time from symptom onset to hospital arrival for 
patients with acute chest pain did not change significantly between intervention and 
control communities over the course of this trial. A recent trial (2000-2006) using a 
nurse-counseling intervention for patients with documented coronary heart disease (CHD) 
that focused on information, emotional issues, and social factors also failed to reduce 
extent of  pre-hospital delay in approximately 3,500 patients with documented CHD.27 
 A limited number of previous studies have examined age and sex differences in 
duration of pre-hospital delay in patients hospitalized with AMI. Several studies have 
found that women  are more likely to delay  seeking timely medical care compared with  
men 23,24,29,41,44  whereas  other studies have suggested that there are  no sex differences in 
patterns  of delay.17,18  The majority of  prior studies have demonstrated that older 
individuals are more likely to delay seeking medical care after developing symptoms of 
AMI,18,23,24 though several studies have failed to find differences in medical care seeking 
behavior according to age.28,29,44 More importantly,  few studies have examined whether 
age and sex  differences in extent  of delay in patients hospitalized with AMI have 
changed over time, particularly from the more generalizable perspective of a population-
based investigation.18,23,24  
Due to national interest in age and sex differences in disease outcomes, the 
increasing number of women and older individuals hospitalized with acute coronary 
disease, and because a number of prior studies have not controlled for the effects of 
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various potentially confounding variables in examining age and sex differences in extent 
of pre-hospital delay, it is important to assess long-term trends in delay patterns among 
different age-sex groups to see if improvement, or lack thereof, is occurring in some 
groups but not others. Targeting of educational efforts to high-risk groups to decrease 
extent of pre-hospital delay may also have an important impact on patient related 
outcomes. Therefore, we  examined age and sex differences, as well as 20 year trends 
(1986-2005), in duration of pre-hospital delay in residents of a large central New England 
metropolitan area hospitalized with validated AMI at all central Massachusetts medical 
centers.6,105  
2.2 Methods 
The Worcester Heart Attack Study is an ongoing population-based investigation 
that is examining long-term trends in the incidence and case-fatality rates of AMI among 
residents of the Worcester metropolitan area hospitalized at all 16 greater Worcester 
medical centers in 15 biennial periods between 1975 and 2005.6,105   Fewer hospitals 
(n=11) have been included during recent study years due to hospital closures, mergers, 
and conversion to chronic care facilities.   
The details of this study have been described previously.6,105   In brief, 
computerized printouts of patients discharged from all greater Worcester hospitals with 
possible AMI were obtained, and International Classification of Disease (ICD) codes for 
possible AMI (ICD-9 codes 410-414, 786.5) were reviewed for purposes of sample 
selection. The vast majority of validated cases of AMI came from ICD-9 diagnostic 
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rubric 410 (AMI), followed by a small number of cases from ICD rubric 411 (other acute 
and subacute forms of CHD). Cases of possible AMI treated at all greater Worcester 
medical centers were independently validated according to predefined criteria for AMI. 
The diagnosis of AMI was made on the basis of the well accepted criteria developed by 
the World Health Organization which includes a suggestive clinical history, serum 
enzyme elevations, and serial electrocardiographic findings during hospitalization; these 
criteria have been previously utilized in other population-based investigations of AMI 
including the MONICA study.97  
Patients who satisfied at least 2 of these 3 criteria, and were residents of the 
Worcester metropolitan area, were included in this population-based investigation. 
Patients, who developed symptoms of AMI after hospital admission, or after an 
interventional procedure or surgery, were excluded as were patients with an unknown 
time of acute symptom onset.  
Data Collection 
Information about patient’s demographic characteristics, medical history, clinical 
presentation, hospital treatment approaches, and hospital discharge status was abstracted 
from the hospital medical records of patients with confirmed AMI. Pre-hospital delay 
was defined as the time interval between the onset of symptoms suggestive of AMI and 
arrival time in the emergency department.18,104  This information was collected by our 
trained nurse and physician reviewers who reviewed any information they could find in 
hospital medical records which described extent of pre-hospital delay from emergency 
personnel, nurses, and physicians notes. Information on pre-hospital delay was collected 
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in minutes (as a continuous variable). This variable was further categorized according to 
cut-points that had been commonly utilized in the published literature, based on the 
distribution of our data, and according to what we considered to be clinically meaningful 
cut-points of pre-hospital delay.  
While information about age was collected from hospital medical records as a 
continuous variable, we described age- specific differences in extent of pre-hospital delay 
using  categories (<65 years, 65-74 years, and ≥ 75 years) that have been previously used 
in this and in other investigations for ease of reporting and for consistency with the 
literature. Candidate variables considered as potential confounders of the association 
between age/sex and pre-hospital delay were chosen based on findings from prior studies 
including study year, race (white vs. non-white), marital status (single, married, divorced, 
widowed), comorbidities (e.g., heart failure, diabetes), time of hospital  admission 
(weekday vs. weekend), time of day (12 am-5:59 am; 6 am-11:59 am; 12 pm-5:59 pm 
and 6 pm-11:59 pm), and AMI order (initial vs. prior), type (Q wave vs. non–Q wave) 
and location (anterior vs. other). Information about whether the AMI was a non–ST-
segment elevation myocardial infarction (NSTEMI) or an ST-segment elevation 
myocardial infarction (STEMI) was recorded beginning in 1997. 
Data Analysis 
Categorical data were compared between patients who delayed ≥2 hours or ≥6 
hours, and those who delayed for shorter intervals, using the chi-square test. Distributions 
of continuous variables were checked and some variables were not normally distributed 
(e.g., serum triglycerides); therefore, Wilcoxon sum rank tests were used to compare the 
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values of all variables between various patient groups according to extent of delay (e.g., 
<2 hours vs. ≥2 hours) for consistency. Patient characteristics were also analyzed 
according to age and sex (data not shown).  
We examined the possible association between age/sex and extent of pre-hospital 
delay using two approaches. In the first approach, we used a median regression model to 
examine the association between age/sex with duration of pre-hospital delay (hours), 
taking into account the skewed distribution of pre-hospital delay.  In addition, we created 
both multinomial logistic and ordered logistic regression models to determine the 
association of age/sex with our principal study outcome expressed as an ordinal variable 
(e.g., pre-hospital delay 0-1.9, 2-5.9, and ≥ 6 hours). Results were similar, and the 
assumptions of ordered logit were met, so we reported the results from our ordered 
logistic regression model.   
In each analysis, a series of regression models were used to examine the impact of 
demographic characteristics, comorbidities, and clinical presentation on the association 
between age/sex and pre-hospital delay. The first model included only age, sex, and study 
year. Model 2 further adjusted for other demographic factors and medical history of 
various cardiovascular diseases and comorbidities. Model 3 was further adjusted for AMI 
associated characteristics and acute presenting symptoms (see footnotes to each table for 
the list of controlling variables). To assess whether any age or sex differences in extent of 
pre-hospital delay have changed over time, 2-way and 3-way interaction terms between 
age, sex, and study year were created and included in each regression model. Since the 
evidence supporting an association between decreased pre-hospital delay and improved 
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short-term outcomes is strongest in patients with STEMI, we repeated all analyses in this 
patient subgroup.  
Since 42% of the study sample had information missing from hospital records on 
extent of pre-hospital delay, we conducted a sensitivity analysis using a propensity-
weighted method to assess whether the missing data influenced our primary study results. 
We constructed logistic regression models predicting missing vs. non-missing data on 
extent of pre-hospital delay using baseline characteristics which yielded a c statistic of 
0.70. Propensity scores for non-missing data were calculated for each patient. We 
estimated the median regression models weighted for 1/propensity score for missing data 
and compared the results with analyses among patients with information available on pre-
hospital delay. All covariates included in our analyses had missing information in less 
than 5% of cases; inasmuch, missing data were not imputed.  
We also used random effect models (random intercept) to assess whether the 
different patient clusters within participating hospitals might have affected our observed 
results. To examine the impact of hospital level effects, we estimated linear random 
effect models with log of pre-hospital delay as the outcome.  
2.3 Results  
 
A total of 10,310 patients were hospitalized with validated AMI at all greater 
Worcester medical centers during the 11 study years between 1986 and 2005. Patients 
who had information missing on pre-hospital delay (42%; n=4,334) were more likely to 
be older and women, to have a history of diabetes, hypertension or heart failure, to have 
developed important clinical complications or to have died during hospitalization, and 
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were less likely to have reported chest pain, and to have an initial, Q-wave, or anterior MI 
compared with patients who had information available on delay time (Appendix 2.1).  
The final study sample consisted of 5,976 patients in whom information on 
duration of pre-hospital delay was available. The average age of this sample, which was 
comprised of approximately three-fifths men, was 67.5 years; of these, 40% were <65 
years, 26% were between the ages of 65-74 years, and 34% were ≥75 years. Women were 
considerably older than men at the time of hospital admission (means: 73 years vs. 64 
years, p<0.001). Among 2,771 patients who were hospitalized for AMI between 1997 and 
2005, approximately 47% were diagnosed as having STEMI at the time of hospital 
admission.  
Patient Characteristics According to Duration of Pre-Hospital Delay  
 Patients who delayed ≥2 hours in seeking medical care after the onset of 
symptoms suggestive of AMI were more likely to be older (≥65 years), female, and 
widowed compared to those who delayed <2 hours (Table 2.1). Patients who delayed 
seeking medical care were more likely to have a history of diabetes, hypertension and 
heart failure, and present at greater Worcester hospitals from 6 am to 6 pm; on the other 
hand, these patients were less likely to have developed a Q-wave and STEMI and to 
report chest pain, shortness of breath, or diaphoresis than patients who sought medical 
care at an earlier time.  Patients who delayed seeking medical care were more likely to 
present with higher heart rates and systolic blood pressure on admission compared to 
patients who exhibited shorter delay (Table 2.1). Demographic and clinical differences 
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between patients who delayed ≥6 hours in seeking medical care and those who delayed < 
6 hours are also displayed in Table 2.1.  
Pre-hospital Delay in Patients Hospitalized with AMI and Trends over Time 
 The overall median duration of pre-hospital delay in our total study population 
was 2 hours (mean: 3.6 hours).  The proportions of patients who delayed <1 hour , 1-1.9 
hours, 2-3.9 hours, 4-5.9 hours, 6-11.9 hours, and ≥12 hours were 18%, 28%, 25%, 9%, 
11%,  and 9%, respectively (Figure 2.1).  Women delayed seeking medical care 
significantly longer than men (Medians: 2.2 hours vs. 2.0 hours, p<0.001).   The median 
durations of pre-hospital delay were 2.0, 2.1, and 2.4 hours in patients <65 years, 65 -74 
years, and in those ≥75 years, respectively (p<0.001).      
 Duration and distribution of pre-hospital delay for patients further stratified 
according to age and sex are presented in Table 2.2.  Over the 2 decade long period under 
study, duration of pre-hospital delay in patients hospitalized with AMI was relatively 
unchanged (Figure 2.2). Similar patterns in the delay time distributions were observed 
between 1986 and 2005. For example, the proportion of patients who delayed ≥2 hours 
and ≥6 hours were 53.6% and 18.4%, respectively, in 1986/1988 (initial 2 study years), 
and were 52.2% and 17.4%, respectively, in 2003/2005 (2 most recent study years).  
Pre-hospital Delay in Patients Hospitalized with AMI According to Age and Sex    
Delay Time Modeled as a Continuous Outcome 
A significant interaction between age and sex in relation to duration of pre-
hospital delay was found when pre-hospital delay was examined as a continuous outcome 
(Table 2.3). Among patients <65 years, there were no differences in pre-hospital delay 
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between men and women. Among patients 65 -74 years, women were more likely to 
delay seeking medical care compared with men; however, among patients ≥75 years, men 
were more likely to have delayed seeking medical care compared with women.  
Overall, compared with men <65 years, other groups, with the exception of 
women <65 years, delayed seeking medical care significantly longer in all 3 regression 
models (Table 2.2, model 3).  Compared with men <65 years, duration of pre-hospital 
delay increased by 0.11  and by  0.61 hours  for  men 65 -74 years and  men ≥75 years, 
and by 0.12, 0.37, and 0.31 hours for women <65 years, women 65-74 years, and  women 
≥75 years, respectively (Table 2.3 model 3). In absolute terms , the adjusted medians of 
pre-hospital delay were 1.96, 2.07, and 2.57 hours for men <65 years,  men 65 -74 years, 
and men ≥75 years, and 2.08,  2.33, and 2.27  hours for women <65 years, women 65-74 
years, and  women ≥75 years, respectively (Table 2.3, model 3).   
The significant 3- way interactions among age, sex, and study period in model 1 
(p=0.004) indicated that the overall age and sex differences in extent of pre-hospital delay 
have changed over time (Table 2.3, figure 2.3A). Adjustment for other variables and 
comorbidities (particularly a  history of diabetes) made the interaction between age, sex, 
and study period no longer statistically significant (p=0.18), suggesting  that more recent 
trends in the increasing frequency of important comorbidities partially  explained the 
narrowing in age and sex differences over time in extent of  pre-hospital delay (Table 2.3, 
Figure 2.3B). Additional adjustment for clinical presentation and AMI associated 
characteristics further contributed to these narrowing trends (Table 2.3, Figure 2.3C).  
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Results from a propensity-weighted adjustment, which took into account missing 
data on delay time, yielded similar results (Appendix 2.2). In random intercept models 
(outcome was log of pre-hospital delay) assessing the effect of different patient clusters 
within hospitals, we obtained a within hospital correlation of 0.04; the estimated 
coefficients and standard errors were similar to models without the random effect, 
suggesting that the effects of cluster data by hospitals were small. 
Delay Time Modeled as an Ordinal Outcome 
Overall odd ratios for delaying seeking medical care after the onset of symptoms 
suggestive of  AMI,  stratified according to age and sex, showed that, compared with men 
<65 years, men ≥75 years and  women ≥65 years  were significantly more likely to delay 
seeking medical care  in all 3 regression  models (Table 2.4).  The interaction between 
age and sex was significant in models further adjusted for clinical presentation only 
(Table 2.4, model 3); among patients <65 years, there were no differences in pre-hospital 
delay between men and women. Among patients 65 -74 years, women were more likely 
to delay seeking medical care compared with men; however, among patients ≥75 years, 
men were more likely to delay seeking acute medical care compared with women.  
Subgroup analyses in patients with STEMI (n=1,299) 
In the subgroup of patients with STEMI (n=1,299), there was a non- significant 3 
way interaction among age, sex, study year, and extent of pre-hospital delay (p=0.88). 
Furthermore, there was no evidence of any interaction between age and sex in relation to 
extent of pre-hospital delay (p=0.24)  
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In absolute terms, the adjusted medians of pre-hospital delay were 1.73,  1.76,  
and 1.89  hours for men <65 years, 65-74 years, and ≥75 years, and 1.66,  2.20, and 2.07  
hours for women <65 years, 65-74 years, and for those  ≥75 years, respectively.   
2.4 Discussion  
 
The results of this study in nearly 6,000 residents of a large central New England 
metropolitan area hospitalized with AMI found that patient’s care seeking behavior after 
the onset of acute coronary symptoms has been relatively unchanged between 1986 and 
2005. In addition, and compared with younger men, other age/sex groups were 
significantly more likely to have delayed  seeking medical care after the onset of 
symptoms suggestive of AMI, with the exception of women <65 years. Differences in 
duration of pre-hospital delay (continuous outcome) according to age and  sex have 
narrowed over time and were largely explained by changes in patient’s comorbidities  
and AMI associated characteristics during the years under study.  
Our results are  consistent with the findings from  previous studies18,23,24 which 
have shown  that older persons were significantly more likely to delay seeking medical 
care  than younger individuals. Older patients are more likely to have atypical symptoms 
of AMI compared with younger patients.36,47,50  Older patients are also more likely to 
have additional comorbidities present,  including diabetes, hypertension, and heart 
failure,20,39,52 which may make patients misinterpret the  symptoms of AMI  and  delay 
seeking medical care. Other factors such as limited health care access, denial and 
embarrassment, and living alone may also have contributed to the longer delays noted in 
older persons. 
54 
 
 
Sex differences in extent of delay were found in patients ≥65 years, but not in 
patients <65 years, which is consistent with the findings  from previous studies.36,44  For 
example, findings from the Northern Sweden MONICA myocardial infarction registry, 
which included approximately 6,500 patients with a confirmed AMI over the period 
1989-2003, demonstrated  that among patients <65 years there were  no sex differences in 
duration of pre-hospital delay; on the other hand, among patients  65-74 years, women 
were more likely to delay seeking medical care  than men.36 Since there was no upper age 
cap in our study, we were able to further stratify older patients into two subgroups, 
finding that women were more likely to delay seeking medical attention than men among 
patients 65-74 years old, whereas men 75 years and older were more likely to delay 
seeking hospital care compared with older women. This may be partially explained by the 
fact that women <75 years old in the present study had more comorbidities present, and 
were less likely to have developed a Q wave and/or STEMI, compared with men; on the 
other hand, in patients 75 years and older this sex profile was reversed. Previous studies 
have shown that these comorbidities are associated with patient’s care seeking 
behavior.20,52,106  
We also found that age and sex differences in duration of pre-hospital delay have 
narrowed over time, and were largely explained by changes in patient’s comorbidity 
profile  and AMI associated characteristics.  These findings are consistent with the results 
from a limited number of other studies.24,52 Data from the National Registry of 
Myocardial Infarction, which  included nearly 480,000  patients hospitalized with STEMI, 
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suggested that age and sex differences in pre-hospital delay  slightly narrowed between 
1995 and 2004.52   
Although we found that age and sex differences in pre-hospital delay  have 
narrowed over time, our findings suggest that overall duration of pre-hospital delay has 
remained relatively constant over time and that approximately one  half of patients who 
presented with AMI to metropolitan Worcester hospitals did so after delaying for at least 
2 hours following the onset of symptoms suggestive of AMI; these results are  consistent 
with the  findings from prior studies.17,19,20  In the present study, all age-sex subgroups 
experienced a relatively long duration of pre-hospital delay (medians > 1.9 hours). These 
results reinforce the need for the development of intervention programs to educate 
patients about the importance of seeking medical care promptly after the onset of 
symptoms suggestive of AMI. This is because excessive delay may increase an 
individual’s risk of sudden cardiac death and may also be associated with delays in the 
receipt of effective hospital therapies, primarily coronary reperfusion therapy.  
Several community intervention trials have been undertaken with the expressed 
purpose  of reducing extent of pre-hospital delay in patients with signs and symptoms of 
AMI; however, 2 recent trials which employed both broad population approaches and 
more personalized interventions107,1087 failed to reduce extent of pre-hospital delay. These 
and earlier findings  suggest that our understanding of the reasons for care seeking 
behavior in patients with symptoms suggestive of AMI is  inadequate as may be our 
educational approaches and intervention efforts.  The findings from the present study 
demonstrated that both older men and women were at greatest risk for prolonged delay. 
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Inasmuch, interventions designed to reduce pre-hospital delay might be primarily focused 
on these high risk groups and address specific issues that may contribute to delay in these 
individuals.   
Further in depth qualitative studies should be carried out in older men and women 
to identify the reasons why these high risk groups fail to react promptly to their 
symptoms of acute coronary disease focusing on their levels of cognition, knowledge, 
and attitudes toward health care. Further studies remain needed to explore the effects of 
educational attainment, extent of insurance coverage, neighborhood level characteristics, 
psychosocial variables, and other factors that may serve as either facilitators or obstacles 
by patients to the more timely seeking of medical care, particularly of those factors that 
may be amenable to change. 
Study Strengths and Limitations  
This study has several strengths including its population-based design that 
captured all validated cases of AMI occurring among residents of the Central 
Massachusetts area hospitalized at all greater Worcester medical centers over a 20 year 
period. However, several limitations need to be kept in mind in interpreting the present 
findings. First, a considerable proportion of patients had data missing on pre-hospital 
delay and missing data differed by age and sex; therefore, our findings should be 
interpreted with appropriate caution. However, we used propensity-weight adjusted 
analysis to take into account missing data and we also examined some simple estimates 
of median delay times assuming missing patients had 50% higher or lower delay times. 
The combined estimated delay time (actual + imputed missing) resulted in similar 
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patterns of differences by age and sex. Second, information about pre-hospital delay was 
abstracted from hospital medical records whose documentation may have varied over 
time and according to patient’s demographic and/or clinical characteristics.  In addition, 
the majority of the study population was White; therefore, the generalizability of our 
findings may be limited. We did not have information available on several patient 
associated characteristics (e.g., socioeconomic status) which may have confounded some 
of the observed associations, nor did we have information on the reasons why patients 
delayed seeking medical care and how these contributory factors may have differed 
according to age and sex.  Finally, since patients who died out of the hospital from AMI 
were not included, the findings may only apply to patients hospitalized with AMI; the 
direction and magnitude of the associations between age/sex and pre-hospital delay in 
patients who died before reaching the hospital may be different from those who are 
hospitalized.   
2.5 Conclusions 
 
The results of our study suggest that duration of pre-hospital delay has remained 
relatively unchanged over time, and the elderly are more likely to delay seeking medical 
attention after the development of symptoms suggestive of AMI compared to younger 
persons. While public educational campaigns and interventions targeted at older 
individuals are needed to encourage patients to seek medical care promptly to maximize 
the benefits of currently available therapies, further research remains needed to identify 
why all patients, including men and women of different ages, delay seeking medical care 
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in the setting of AMI and the best means to encourage patients to seek medical care in a 
timely fashion. 
Acknowledgement: This research was made possible by the cooperation of participating 
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Table 2.1 Characteristics of Patients with Acute Myocardial Infarction (AMI) according 
to Extent of Delay in Seeking Medical Care 
 
 
Characteristic 
< 2 hours 
(n=2,762) 
≥ 2 hours 
(n=3,267) 
P-
value 
< 6 hours 
(n=4791) 
≥ 6 hours 
(n=1,238) 
P-
value 
Age (years, mean) 66.2 68.7 0.004 67.4 68.2 0.15 
Age (years, %)       
    <65  43.5 36.2 <0.001 40.3 36.4 0.002 
    65-74  25.7 26.2  25.7 26.9  
    ≥75  30.8 37.6  23.0 36.6  
Female (%) 36.2 40.8 <0.001 38.4 39.7 0.43 
White (%) 94.6 94.8 0.82 94.5 95.4 0.26 
Marital Status (%)       
     Single 10.9 9.7 0.001 10.1 10.7 0.71 
     Married 63.3 61.1  62.5 60.3  
     Divorced 7.1 6.4  6.6 6.9  
     Widowed 18.7 22.7  20.6 21.9  
Medical history (%)       
     Atrial fibrillation 9.4 9.3 0.85 9.3 9.6 0.76 
     Diabetes mellitus 24.9 30.1 <0.001 27.2 29.8 0.07 
     Hypertension 58.4 61.6 0.012 60.6 58.4 0.17 
     Heart failure 15.0 16.9 0.047 16.0 16.2 0.90 
     Stroke 8.7 9.2 0.55 8.9 9.1 0.84 
     PCI* 34.9 34.7 0.94 36.6 25.5 0.06 
     CABG 6.4 5.4 0.12 6.0 5.2 0.25 
AMI characteristics (%)       
     Initial 66.4 67.1 0.52 65.9 70.1 0.005 
     Q-wave 42.8 39.2 0.006 40.3 42.8 0.13 
     Anterior 30.3 31.8 0.23 30.7 32.9 0.15 
     STEMI† 52.6 41.7 <0.001 48.4 40.5 0.001 
Acute symptoms (%)       
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     Chest pain 39.5 35.0 <0.001 38.1 33.2 0.002 
     Shortness of breath 28.5 24.6 0.001 27.3 22.9 0.002 
     Nausea 18.4 16.9 0.13 17.9 16.6 0.27 
     Diaphoresis  25.5 19.3 <0.001 23.6 15.9 <0.001 
     Fatigue 5.3 5.5 0.80 5.2 6.1 0.21 
Weekday hospitalization (%) 70.6 71.5 0.19 71.2 72.4 0.40 
Time of day hospitalization (%)       
    12am-5:59 am 21.6 18.6 <0.001 22.1 12.0 <0.001 
    6-11:59 am 30.6 32.2  29.8 37.9  
    12 pm-5:59 pm 25.2 28.7  25.8 31.9  
    6 pm-11:59 pm 22.7 20.4  22.3 18.2  
DNR order‡ (%) 14.4 15.8 0.20 15.1 15.1 0.97 
Clinical presentations, median       
    Heart rate, beats/min 80 82 <0.001 80 83 0.001 
    Systolic BP, mmHg 142 145 0.018 144 145 0.36 
    Diastolic BP, mmHg 80 80 0.89 80 80 0.55 
    BMI (kg/m2)¶ 27.1 27.0 0.31 27.1 26.8 0.59 
Laboratory findings, median        
    Cholesterol (mg/dl) 198 201 0.14 199 203 0.08 
    LDL (mg/dl) 109 112 0.18 109 116 0.034 
    Triglyceride (mg/dl) 121 123 0.97 120 130 0.34 
    Glucose (mg/dl) 145 147 0.27 147 142 0.019 
    Creatinine (mg/dl) 1.1 1.1 0.56 1.1 1.1 0.99 
*Data on history of PCI were recorded beginning in 2003 and available for 546 patients. 
†Data were recorded beginning in 1997 and available for 2,771 patients. 
‡Data were recorded beginning in 1991 and available for 4,384 patients. 
¶Data were recorded beginning in 1995 and available for 2,931 patients. 
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Table 2.2 Unadjusted Pre-hospital Delay Duration and Distribution according to Age and 
Sex 
 Men Women 
 <65y 65-74y ≥ 75y <65y 65-74y ≥ 75y 
Mean (SD), hour 4.00 (5.8) 4.65 (8.0) 5.21 (9.3) 4.50 (7.6) 5.00 (7.0) 4.63(6.4) 
Median (IQR), 
hour 
1.92  
(1.00-4.17) 
2.00  
(1.00-4.65) 
2.25  
(1.25-5.18) 
2.00  
(1.03-4.67) 
2.43 
 (1.30-5.50) 
2.28  
(1.22-5.10) 
Distribution (%)       
   0-1.9 h 51 47 39 47 41 41 
   2-5.9 h 30 32 38 34 36 38 
   ≥ 6 h 19 21 23 19 23 21 
SD: Standard deviation; IQR: inter-quartile range
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Table 2.3 Overall Association between Age/Sex and Duration of Pre-hospital Delay 
 
 Men Women P 
value†  
P 
value‡  < 65 y 65-75 y ≥ 75 y < 65 y 65-75 y ≥ 75 y 
Difference in Median of Pre-hospital Delay ( 95% CIs), hours 
Model 1 0 
reference 
0.12 
(-0.07; 0.30) 
0.62 
(0.43; 0.81) 
0.13 
(-0.09; 0.36) 
0.48 
(0.27; 0.70) 
0.4 
(0.23;0.57) 
0.001 0.004 
 
Model 2 0 
reference 
0.12 
(-0.13; 0.36) 
0.55 
(0.29; 0.82) 
0.14 
(-0.16; 0.44) 
0.37 
(0.07; 0.66) 
0.37 
(0.10;0.65) 
0.10 0.18 
Model 3 0 
reference 
0.11 
(-0.10; 0.32) 
0.61 
(0.39; 0.84) 
0.12 
(-0.14; 0.37) 
0.37 
(0.21; 0.72) 
0.31 
(0.08;0.55) 
0.001 0.69 
Absolute Medians of Pre-hospital Delay ( 95% CIs), hours 
Model 1 1.89 
(1.78-1.99) 
2.01 
(1.85-2.15) 
 
2.51 
(2.35-2.66) 
 
2.02 
(1.82-2.22) 
 
2.37 
(2.18-2.56) 
 
2.29 
(2.15-2.42) 
0.001 0.004 
Model 2 1.94 
(1.79-2.09) 
2.06 
(1.86-2.26) 
 
2.49 
(2.29-2.70) 
 
2.08 
(1.82-2.34) 
 
2.31 
(2.06-2.56) 
 
2.31 
(2.11-2.52) 
 
0.10 0.18 
Model 3 1.96 
(1.83-2.09) 
2.07 
(1.90-2.24) 
 
2.57 
(2.40-2.75) 
 
2.08 
(1.85-2.30) 
 
2.33 
(2.22-2.63) 
 
2.27 
(2.10-2.45) 
 
0.001 0.69 
Model 1: Included age, sex, and study year. 
Model 2: Further adjusted for race, marital status, and history of angina, diabetes, heart 
failure, hypertension, stroke, and CABG. 
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Model 3: Further adjusted for clinical presentation including day of week admission, time 
of day, chest pain, AMI order (initial vs. prior), AMI type (Q wave vs. non-Q wave), and 
AMI location (anterior vs. inferior/posterior). 
Notes: Information on DNR and STEMI was recorded beginning in 1991 and 1997, 
respectively; therefore, they were not included as controlling variables in regression 
model #3. 
 
† p values for interaction between age and sex 
‡ p values for interaction among age, sex, and study year 
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Table 2.4 Overall Odds Ratios (95% CIs) From Ordered Logistic Model for Extent of 
Delay in Seeking Medical Care According to Age and Sex   
 
 Men Women P 
value†  
P  
value‡  < 65 y 65-75 y ≥ 75 y < 65 y 65-75 y ≥ 75 y 
Model 1 1.00 1.14 
(0.98-1.32) 
1.51 
(1.31-1.75) 
1.15 
(0.96-1.37) 
1.43 
(1.21-1.70) 
1.43 
(1.25-1.64) 
0.06 0.12 
Model 2 1.00 1.13 
(0.97-1.31) 
1.50 
(1.28-1.75) 
1.12 
(0.93-1.34) 
1.34 
(1.11-1.61) 
1.34 
(1.14-1.58) 
0.10 0.19 
Model 3 1.00 1.12 
(0.96-1.32) 
1.55 
(1.31-1.84) 
1.11 
(0.91-1.35) 
1.34 
(1.11-1.62) 
1.28 
(1.07-1.53) 
0.013 0.56 
 
Model 1: Included age, sex, and study year. 
Model 2: Further adjusted for race, marital status, and history of angina, diabetes, heart 
failure, hypertension, stroke, and CABG.  
Model 3: Further adjusted for clinical presentation including day of week admission, time 
of day, chest pain, AMI order (initial vs. prior), AMI type (Q wave vs. non-Q wave), and 
AMI location (anterior vs. inferior/posterior). 
Notes: Information on DNR and STEMI was recorded beginning in 1991 and 1997, 
respectively; therefore, these variables were not included in regression model #3 
† p values for interaction between age and sex 
‡ p values for interaction among age, sex, and study year  
 
65 
 
 
Figure 2.1 Distribution of Pre-Hospital Delay in Patients Hospitalized with Acute 
Myocardial Infarction 
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Figure 2.2 Duration of Pre-Hospital Delay According to Study Year 
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Figure 2.3 Age and Sex Differences in Duration of Pre-hospital Delay according Study 
Period 
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Appendix 2.1: Characteristics of Patients with and without Information on Pre-hospital 
Delay 
 Data on Pre-hospital Delay  
 
Characteristics (n, %) 
Available 
(n=5,967) 
Not available 
(n=4,358) 
 
P value 
Age, mean (years) 68±14 73±3 <0.001 
Female 2,308(38.7) 2,101(48.2) <0.001 
Age/Sex group  
Men 
   
     <65 y 1825(50) 730(32) <0.001 
     65-74 y 936(26) 609(27)  
     ≥ 75y 893(24) 914(41)  
Female    
     <65 y 541(24) 314(15) <0.001 
     65-74 y 609(26) 483(23)  
     ≥ 75y 1153(50) 1303(62)  
White 5,463(94.7) 3,970(94.0) 0.13 
Medical history    
     Diabetes 1,655(27.7) 1,436(33.0) <0.001 
     Hypertension 3,587(60.1) 2,755(63.3) <0.001 
     Heart Failure 957(16.0) 1,148(26.4) <0.001 
AMI characteristics        
     Initial 3974(67) 2749(63) <0.001 
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     Q-wave 2221(41) 1142(30) <0.001 
     Anterior 1695(31) 1060(28) <0.001 
     STEMI* 1299(47) 772(30) <0.001 
   Shock 318(5) 347(8) <0.001 
Hospital mortality 553(9) 759(17) <0.001 
*Information on STEMI was recorded beginning in 1997. 
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Appendix 2.2: Overall Association between Age/Sex and Duration of Pre-hospital 
Delay: Results from Propensity- weight Adjusted Method 
 
 Men Women P 
value†  
P 
value‡  < 65 y 65-75 y ≥ 75 y < 65 y 65-75 y ≥ 75 y 
Difference in Median of Pre-hospital Delay ( 95% CIs), hours 
Model 1 
 
0 
(reference) 
0.12 
(-0.09; 0.33) 
0.59 
(0.36; 0.80) 
0.20 
(-0.06; 0.46) 
0.66 
(0.41; 0.90) 
0.3 
(0.10;0.50) 
<0.001 0.074 
 
         
Model 2 0 
(reference) 
0.14 
(-0.11; 0.39) 
0.62 
(0.35; 0.90) 
0.22 
(-0.09; 0.53) 
0.53 
(0.23; 0.84) 
0.29 
(0.001;058) 
0.002 0.85 
Model 3 0 
(reference) 
0.15 
(-0.60; 0.35) 
0.56 
(0.34; 0.78) 
0.16 
(-0.09; 0.41) 
0.52 
(0.27; 0.76) 
0.30 
(0.07;0.55) 
0.001 0.50 
Absolute Medians of Pre-hospital Delay ( 95% CIs), hours 
Model 1 
 
1.92 
(1.80-2.04) 
2.04 
(1.86-2.21) 
 
2.50 
(2.35-2.68) 
 
2.12 
(1.89-2.35) 
 
2.57 
(2.36-2.79) 
 
2.22 
(2.06-2.38) 
 
<0.001 0.074 
Model 2 1.96 
(1.79-2.12) 
2.09 
(1.88-2.31) 
 
2.58 
(2.36-2.80) 
 
2.18 
(1.90-2.46) 
 
2.49 
(2.23-2.76) 
 
2.24 
(2.03-2.46) 
 
0.002 0.85 
Model 3 1.98 
(1.85-2.11) 
2.13 
(1.96-2.29) 
 
2.54 
(2.37-2.72) 
 
2.14 
(1.92-2.36) 
 
2.50 
(2.29-2.70) 
 
2.29 
(2.12-2.45) 
 
0.001 0.50 
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Abstract 
Background 
A limited number of studies have examined age and sex differences, and 
potentially changing trends, in cardiac medication and procedure use in patients 
hospitalized with an acute coronary syndrome (ACS).  
Methods 
 Using data from a large multinational study, we examined  age and sex 
differences, and changing trends (1999-2007) therein, in the hospital use of evidence-
based therapies in patients hospitalized with an ACS using data from the Global Registry 
of Acute Coronary Events (n=50,096).  
Results 
After adjustment for several  variables, in comparison with men <65 years, 
patients in other age-sex strata had a significantly  lower odds of receiving aspirin (Odds 
ratios for men 65-74 years, 75-84 years, and ≥85 years,  women <65 years, 65-74 years, 
75-84 years, and ≥85 years were 0.86, 0.84, 0.72, 0.80, 0.86, 0.68 and 0.46, respectively), 
angiotensin converting enzyme inhibitors or angiotensin II receptor blockers (Odds ratios, 
1.08, 1.01, 0,71, 0.83, 0.90, 0.89, and 0.63), beta blockers (Odds ratios, 0.66, 0.52, 0.53, 
0.67, 0.54, 0.53, and 0.52), statins (Odds ratios, 0.72, 0.49, 0.29, 0.82, 0.68, 0.44, and 
0.22), and undergoing coronary artery bypass graft surgery or a percutaneous coronary 
intervention (Odds ratios, 0.79, 0.53, 0.21, 0.64, 0.57, 0.38 and 0.13) during their acute 
hospitalization.  Age and sex differences in the receipt of these therapies remained 
relatively unchanged during the period under study 
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Conclusions 
While there were increasing trends in the use of evidence-based medications and 
cardiac procedures over time, important gaps in the utilization of effective cardiac 
treatment modalities persist in elderly patients and younger women.  
Word count: 250 
Keywords: aging, sex, acute coronary syndromes, effective cardiac therapies  
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3.1 Introduction 
 
Over the past several decades, a variety of clinical trials have evaluated the use of 
different treatment strategies in patients hospitalized with an acute coronary syndrome 
(ACS),  finding that various  treatment regimens can reduce the risk of hospital 
complications and improve short-term prognosis.109-111 However, patients enrolled in 
clinical trials often need to satisfy stringent inclusion and exclusion criteria, leading to the 
omission of several at-risk patient groups, such as the elderly, as well as potentially 
limited generalizability to patients treated in the broader community setting.  
Even though published clinical evidence does not support withholding effective 
cardiac therapies on the basis of age,72,73 elderly patients hospitalized with an ACS are 
often treated less aggressively than younger patients.75,76 Moreover, despite the greater 
prevalence of coronary heart disease in men as compared with women, 5,77 women are 
more likely to experience adverse in-hospital and post-discharge outcomes 78,79 in the 
setting of an ACS. Women’s poorer prognosis may be due to differences in demographic 
and clinical characteristics, pathophysiology of acute coronary disease, or to the lower 
use of effective management strategies as compared with men.17,78  
Several prior studies have examined possible age and sex differences in cardiac 
medication and procedure use in patients hospitalized with an ACS.17,48,76,83,85,86 However, 
a limited number of studies have examined these associations from the perspective of a 
multinational investigation. Moreover, little contemporary research has been conducted 
examining potentially changing age and sex differences in the utilization of evidence-
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based therapies in patients hospitalized with an ACS, and whether differences in the 
receipt of effective cardiac therapies have narrowed over time between men and women 
of different ages.  
The objectives of this large multi-site observational study were to describe age 
and sex differences in the hospital use of several evidence-based cardiac therapies, 
namely aspirin, angiotensin -converting (ACE) inhibitors/ angiotensin II receptor 
blockers (ARBs), beta blockers, and statins, as well as receipt of invasive cardiac 
procedures, in patients hospitalized with an ACS. A secondary study objective was to 
examine changing trends (1999-2007) in the hospital use of these treatment strategies 
according to patient’s age and sex. Data from the GRACE (Global Registry of Acute 
Coronary Events) study were used for purposes of this investigation.7,8 
3.2  Methods 
 
 
Details on the GRACE registry and methods of patient identification and data 
collection have been previously published.7,8  Study data were contributed by 106 
hospitals located in 14 countries in North and South America, Europe, Australia and New 
Zealand.  
Patients entered in the registry had to be at least 18 years old and alive at the time 
of hospital presentation, be admitted for an ACS as a presumptive diagnosis, and have at 
least 1 of the following present: electrocardiographic changes consistent with an ACS, 
serial increases in serum biochemical markers of cardiac necrosis, and/or documentation 
of coronary artery disease.  
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To ensure the enrollment of an unbiased population, the first 10 consecutive, 
eligible patients were recruited from each site on a monthly basis. Data were collected by 
trained abstractors using standardized case report forms. Demographic characteristics, 
medical history, presenting symptoms, duration of pre-hospital delay, biochemical and 
electrocardiographic findings, treatment practices, and a variety of hospital outcome data 
were collected.7,8 The medical therapies prescribed for patients enrolled in the GRACE 
registry were at the discretion of the treating physicians at participating study hospitals. . 
Standardized definitions of all patient-related variables, clinical diagnoses, and hospital 
complications and outcomes were utilized.8 All cases of confirmed ACS were assigned to 
1 of the following categories: ST-segment elevation myocardial infarction (STEMI), 
non–ST-segment elevation myocardial infarction (NSTEMI), or unstable angina (UA) 
using standardized case definitions.7,8 Patients who were transferred from another 
hospital or to another health care facility were excluded from the present study. 
The present analyses were carried out only  in patients who did not have 
exclusions to the receipt of the evidence-based cardiac therapies examined.7,8 The 
exclusion criteria for receipt of each of the cardiac medications under study included the 
following:  
 Aspirin: history of bleeding or hemorrhagic stroke, in-hospital bleeding, or 
hemorrhagic stroke; on warfarin therapy; and other contraindications to aspirin.  
 Angiotensin-converting enzyme inhibitors: hospital development of cardiogenic 
shock; serum creatinine >2.5 mg/dL; and a previous adverse reaction to ACE 
inhibitors.  
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 Beta blockers: pulse <60 beats per minute while not on beta blockers; 
atrioventricular block; systolic blood pressure <90 mm Hg; development of 
cardiogenic shock during hospitalization; and other contraindications to beta 
blockers.  
 Statins: no additional exclusion criteria.  
These criteria were based on contemporary published guidelines, were designed to 
be permissive, and could be noted by the GRACE investigators without the specific 
contraindication being indicated. The receipt of effective cardiac medications and 
coronary interventional procedures were the primary study outcomes. 
Data Analysis 
Categorical data were summarized as percentages and were compared between 
patients of various age strata (<65, 65-74, 75-84, ≥85 years) in both sexes using the chi-
square test. Continuous variables were presented as medians (inter-quartile range, IQR) 
and were tested for possible differences according age and sex using the Kruskal-Wallis 
test.   
We examined the possible association between age/sex and the receipt of each of 
these treatments, as well as receipt of 3 or more of these medications in combination, in 
all eligible patients and in subgroups further defined according to type of ACS (STEMI 
and NSTEMI/UA), using a series of multivariable logistic regression models to control 
for the potentially confounding effects of demographic characteristics (other than age and 
sex), comorbidities, and clinical characteristics. Model 1 included age, sex, and study 
year. Model 2 further adjusted for geographic region, type of hospital (teaching vs. other), 
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and medical history of cardiovascular disease. Model 3 further adjusted for the 8 factors 
included  in  the GRACE hospital  risk model.98 To test whether any age or sex 
differences in the utilization of these therapeutic approaches have changed over time, 2-
way and 3-way interaction terms among age, sex, and study year were created and 
included in each regression model. Likelihood ratio tests were used to test nested models 
with and without interaction terms. Random effect models were used to assess whether 
the different patient clusters within geographic regions affected our observed results. All 
analyses were performed using STATA 10.0. 
3.3 Results 
 
The study population consisted of 50,096 patients hospitalized with an ACS, who 
were enrolled in the GRACE registry between April, 1999 and December, 2007. The 
average  age of study patients, which was comprised of approximately two-thirds men,  
was 66.3 years; 45.2% of patients were <65 years,  25.9% were 65-74 years, 21.6% were 
75-84 years, and 7.3% of patients were ≥ 85 years. Women were considerably older than 
men at the time of hospital admission (mean: 70.7 years vs. 64.0 years). In this patient 
population, 35.2%, 32.3%, and 32.5% were diagnosed as having STEMI, NSTEMI, and 
UA, respectively, at the time of hospital admission for an ACS.  
Baseline Characteristics 
The proportion of patients with a history of MI, atrial fibrillation, heart failure, 
hypertension, kidney disease, and stroke increased with advancing age in both sexes 
(Table 3.1). Within the same age strata, women were more likely to report a history of 
hypertension or heart failure, but were less likely to have a history of MI, than men. 
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Older patients were more likely to have multiple co-morbidities present than younger 
patients in both sexes. In 3 of the 4 age strata, women were more likely to have multiple 
co-morbidities previously diagnosed than men (Table 3.1). 
In general, heart rate, serum creatinine, and serum glucose levels increased with 
advancing age in both sexes; on the other hand, serum levels of cholesterol and 
triglycerides, and patient’s body mass index, decreased with advancing age in both 
women and men (Table 3.2).  Within the same age strata, women were more likely to 
present at participating GRACE hospitals after more prolonged delay following the onset 
of acute coronary symptoms, have higher systolic blood pressure, heart rate, and serum 
cholesterol findings, but lower serum creatinine levels, compared with men. Older 
patients and women were more likely to be classified as presenting in a higher Killip 
class at the time of hospital admission than younger patients and men. The proportion of 
patients with STEMI increased with advancing age in women but declined with 
advancing age in men (Table 3.2). 
Trends in the use of Evidence-Based Medications and Cardiac Procedures  
The use of aspirin during hospitalization for an ACS remained relatively stable 
over time (94% utilization in 1999; 95% in 2007). Moderate increases were observed in 
the prescribing of ACE inhibitors/ARBs (57% in 1999 vs. 79% in 2007) and beta 
blockers (81% in 1999 vs. 92% in 2007) (p<0.001). The hospital use of statins increased 
significantly from 39% in 1999 to 83% in 2007 (p<0.001). The use of 3 or more effective 
cardiac medications increased from 57% in 1999 to 87% in 2007 (p<0.001). The use of 
combination evidence-based medications increased in both women and men and in 
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patients of all age strata during the period under study (Figure 3.1).  The use of coronary 
reperfusion and revascularization strategies (either CABG surgery or PCI) during 
hospitalization also increased significantly over time from 28% in 1999 to 51% in 2007 
(p<0.001).  
Use of Evidence-Based Medications and Cardiac Procedures According to Age and 
Sex  
The use of aspirin and beta blockers during hospitalization for an ACS declined 
with advancing age (Table 3.3). Similarly, older patients were less likely to have 
undergone various cardiac procedures than younger patients. Within the same age groups, 
women were consistently less likely to be treated with aspirin and statins compared with 
men. Women in all age groups were much less likely to have undergone CABG surgery 
or PCI than men of similar ages.  
Multivariable Analyses  
The non significant 2-way and 3-way interactions among age, sex, and study 
period indicated that age and sex differences in the use of these medications (single or 
multiple) and cardiac procedures have remained relatively unchanged over time (Table 
3.4 and Figure 3.2). Since the results of regression models 2 and 3 were similar, overall 
adjusted odds ratios for the utilization of single cardiac medications and procedures 
according to age and sex from model 3 are presented (Table 3.4).  
Aspirin 
In comparison with men <65 years, women had a significantly lower odds of 
receiving aspirin with the exception of women 65-74 years (Table 3.4). In examining the 
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association between age/sex and the use of aspirin stratified according to type of ACS, in 
patients with NSTEMI/UA, compared with men <65 years, women ≥75 years had a 
significantly lower odds of receiving aspirin; a similar  pattern was observed in patients 
with STEMI. There was no evidence of an interaction between age and sex with regards 
to aspirin use in all patients as well as in patients classified according to type of ACS 
(Table 3.4).   
ACE inhibitors and/or ARBs 
In comparison to men <65 years, men ≥85 years, and women had a significantly 
lower odds of receiving ACE inhibitors or ARBs during their acute hospitalization. In 
patients with NSTEMI/UA, compared with men <65 years, women <65 years and men 
and women ≥ 85 years had a significantly lower odds of receiving these medications.  In 
patients with STEMI, compared with men <65 years, men and women ≥85 years had a 
significantly lower odds of receiving these medications. There was no evidence of an 
interaction between age and sex with the use of these medications in all patients as well 
as in patients with different ACS types (Table 3.4).   
Beta blockers 
In all patients, after adjustment for several potential confounders, in comparison 
with men <65 years, other age and sex groups had a significantly lower odds of receiving 
beta blockers during hospitalization (Table 3.4).  Interactions between age and sex were 
statistically significant; in patients <75 years, women were less likely to be treated with 
beta blockers while there were no sex differences in the use of beta blockers in older 
patients (Table 3.4).  
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In patients with NSTEMI/UA, similar results were observed (Table 3.4).  In 
patients with STEMI, while relatively similar patterns were observed, there was no 
evidence of an interaction between age and sex in relation to beta blocker utilization 
(Table 3.4).   
Statins 
In comparison with men <65 years, other age-sex strata had a significantly lower 
odds of receiving statins (Table 3.4). In examining the association between age/sex and 
the use of statins stratified according to type of ACS, similar patterns were observed in 
both NSTEMI/UA and STEMI patients. There was no evidence of an interaction between 
age and sex in relation to the use of statins in all patients as well as in subgroups of 
patients further classified according to type of ACS (Table 3.4).   
CABG or PCI 
After adjustment for several potential confounders, in comparison to men <65 
years, other age-sex strata had a significantly lower odds of undergoing these cardiac 
procedures during their acute hospitalization. In examining these associations stratified 
according to type of ACS, similar patterns were observed. There was no evidence of an 
interaction between age and sex in relation to the use of these procedures in all patients as 
well as in subgroups of patients with an ACS (Table 3.4). 
Multiple Cardiac Medications 
In comparison with men <65 years, other age and sex groups had a significantly 
lower odds of receiving ≥3 effective cardiac medications during their index 
hospitalization (Table 3.4).  Interactions between age and sex were statistically 
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significant; in patients <65 years, women were less likely to be treated with ≥3 
medications (Adjusted OR: 0.76; 95% CIs: 0.67-0.86), while there were no sex 
differences in the use of ≥3 medications in older patients. In examining these associations 
stratified according to type of ACS, similar patterns were observed though there was no 
evidence of an interaction between age and sex with regards to the use of ≥3 effective 
medications (Table 3.4).   
Results from random effect models assessing the effects of the different patient 
clusters within geographic regions provided similar conclusions (data not shown).  
3.4 Discussion 
 
The results of this large contemporary multinational study demonstrate a marked 
increase in the hospital use of several key evidence-based cardiac medications, CABG 
surgery, and PCI in men and women of various age strata who were hospitalized with an 
ACS between 1999 and 2007.  Despite encouraging increases in prescribing practices 
over time, age and sex differences with regards to the prescribing of most effective 
cardiac therapies have not changed significantly during the period under study. In 
comparison with men <65 years, patients in other age-sex strata were less likely to be 
treated with these medications and cardiac procedures. There was some evidence, 
however, which suggested that there were interactions between age and sex with the use 
of beta blockers and multiple medications; younger women were less likely to be treated 
with these medications during hospitalization compared with younger men, while there 
were no sex differences in these outcomes in older patients. 
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Improving Trends in the Use of Evidence-Based Medications and Cardiac 
Procedures  
Increasing use of evidence-based medications and cardiac procedures in patients 
hospitalized with an ACS were observed in the present study, irrespective of changes in 
patient’s demographic and clinical characteristics. Our findings are consistent with  the 
results of  several previous studies which have examined the use of various treatment 
practices in  patients hospitalized with acute coronary disease between the mid-1970s and 
early 2000s.47,77  
Increases in the administration of effective cardiac treatment practices over time 
is likely  due to the accumulating evidence from published clinical trials and American 
College of Cardiology/ American Heart Association  and European guidelines that have 
demonstrated the benefits associated with the use of these medications and procedures in 
reducing the  risk of complications and death  in patients with  an ACS.62,63,112 In addition, 
other factors such as increases in patient’s and physician’s awareness about different 
treatment options through educational campaigns, and hospital quality improvement 
programs, are  likely to have contributed to the  increased use  of these evidence-based 
therapies  as well.   
Age and Sex Differences in the Receipt of Effective Cardiac Treatment Regimens 
 
In the present study, we found that the differences between patients of different 
ages within the same sex were larger than the differences noted between men and women 
within the same age strata, suggesting that age, rather than sex, differences in the receipt 
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of different cardiac therapies are more important. Similar patterns were observed in 
subgroups defined according to type of ACS. 
Our findings are consistent with the results of previous studies.48,51,76,113,114  For 
example, a  retrospective cohort study of more than 17,000 patients enrolled between  
1995-2001 in the ARIAM study (Analysis of Delay in AMI), a multi-center registry of 
patients with AMI admitted to 119 Spanish hospitals, found that older patients  were less 
likely to be prescribed  beta blockers,  but were more likely to be prescribed ACE 
inhibitors, than younger patients.51 Data from the Second National Registry of 
Myocardial Infarction suggested that younger  patients were more than twice as likely   to 
undergo cardiac catheterization in comparison to  patients ≥70 years.113  
Age differences in the hospital treatment of patients with  an ACS may be 
partially explained by the fact that older patients are  more likely to have multiple co-
morbidities present,17,86,87 and present with more contraindications to treatment practices, 
which may limit their receipt of more effective treatment regimens; however, in the 
present study, we restricted our analyses to eligible patients only, and age differences in 
various treatment practices  still existed. Older patients tend to present with more  
atypical  signs and symptoms of acute coronary disease  than younger patients and 
men,115  which can make their diagnosis and management all the more difficult. 
Furthermore, lower use of medications and  interventional  cardiac procedures in older 
patients may be due to the  higher rates of complications in these patients,114,116 which 
may make both physicians and patients more  reluctant to use these interventions. Since 
older patients have been generally excluded from, or were included in small numbers, in 
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earlier clinical trials, the evidence of effectiveness of these treatments in these individuals 
is limited. Based on these and other considerations, physicians may be reluctant to treat 
elderly patients more aggressively. It is also possible that some physicians believe that 
age is a contraindication to some medications in patients who have suffered an ACS. On 
the other hand, the American College of Cardiology/ American Heart Association  and 
European guidelines emphasize that  all medications that are used for the management of 
patients with an ACS should not be differentially utilized on the basis of age.62,63,112 
Inasmuch, physicians should prescribe these medications to older patients when there are  
no contraindications present  as often as they do to younger patients with proper 
precautions noted (e.g., starting with lower doses and monitoring closely for toxicity).   
Our results suggest that women were less likely to be treated with beta blockers 
and multiple medications among younger patients only, particularly in patients with 
NSTEMI/UA.  This finding is consistent with a study of 1,059 patients with AMI in the 
Hospital In-Patient Enquiry (HIPE) that was conducted between 1992 and 1994. In this 
study,  in younger patients (<65 years), women were significantly less likely to receive 
thrombolytic therapy compared with men but there were no sex differences in the 
administration of  thrombolytic agents in older patients.117  Other previous studies have 
not examined sex differences in treatment practices stratified according to age in patients 
with an ACS; therefore, it is difficult to compare their results with those of the present 
study. For example, in the  HELIOS study which included 1,840 patients with AMI 
admitted to 31 hospitals in Greece during  the mid -2000s,  women were less likely to be 
treated with aspirin, beta blockers, and statins, but were more likely to be treated with 
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ACE inhibitors/ARBs,  than men during hospitalization for AMI.87 A recent report from 
the large AMIS Plus registry in Switzerland showed that women were approximately 
one-third  less likely to undergo PCI than men  between 1997 and 2006, though the 
investigators did not examine whether sex differences in the administration  of these 
procedures remained during the period under study.81   
In contrast, several studies have found that there were  no differences between 
men and women in the use of several cardiac medications and interventional procedures 
in patients hospitalized with acute coronary disease.17,83,87,28 For example, findings from 
the MITRA (Maximal Individual The Rapy of Acute myocardial infarction) registry in 
Germany showed that there were no differences between men and women with regards to  
the receipt of aspirin, beta blockers, and  ACE inhibitors during the  first 48 hours of 
hospitalization in  patients hospitalized with AMI.86  Some of the discrepancies observed 
with regards to these study findings may be partially attributed to the different 
demographic and clinical characteristics of the respective study populations, time period 
under study, and the fact that none of these studies simultaneously examined age and sex 
differences in the receipt of these treatment regimens as we did in the present study.  
The reasons for underutilization of beta blockers and multiple effective cardiac 
medications in younger women are unclear. This may be partially explained by the fact 
that younger women have  lower incidence rates   of ACS, and  are more likely to 
experience atypical symptoms115, particularly in patients with UA, which makes their 
diagnosis and management more challenging.  In addition, younger women may be less 
likely to be cared  for by a cardiologist during their hospitalization96, which can 
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contribute to underutilization of effective medications. Finally, younger women have 
been shown to be  more likely to develop important clinical complications than younger 
men during hospitalization117, which could prevent younger women from receiving these 
medications. More studies  need to be carried out to understand the reasons for the 
underutilization of effective treatment regimens in younger women.94 Educational 
campaigns should continue to target older patients and younger women with regards to 
the receipt of effective cardiac treatments in the setting of an ACS as contemporary gaps 
in their more optimal management continue to remain. 
Trends in Age and Sex differences in Hospital Treatment Practices 
In examining changing trends in the utilization of evidence -based medications 
and interventional procedures, our results suggest that age and sex gaps in the utilization 
of most medications have not changed significantly over time.  Our findings are 
consistent with the  findings from the Nationwide Inpatient Sample which found  that 
women were less likely to undergo CABG surgery than men between 1995 and 2001 and 
disparities  in the use of this procedure remained over time.17 These and other findings 
suggest the need for greater understanding of the reasons underlying these treatment 
disparities and for the development of educational interventions and targeted programs to 
enhance the more optimal treatment of these high risk patients. 
Study Strengths and Limitations 
The GRACE study is the largest multinational registry to include the complete 
spectrum of patients hospitalized with an ACS. Standardized criteria are employed for 
defining ACS and hospital outcomes and rigorous quality control and audit measures are 
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employed. ”Real-life” observational studies such as GRACE provide data on a 
heterogeneous population of patients that includes groups who are often under-
represented in randomized trials, including  women and  the elderly.8  
On the other hand, as an observational study, GRACE is subject to certain 
inherent limitations and potential biases that must be kept in mind in interpreting the 
study results. Treatments were given according to individual physicians’ decisions and 
not through the use of standardized treatment protocols. While currently recommended 
criteria were utilized to characterize patients who were eligible for the receipt of the 
cardiac medications examined, due to our reliance on data obtained from medical records, 
questions might be raised about our ability to characterize patient’s eligibility status. 
Furthermore, we did not have information available on several patient associated 
characteristics (e.g., socioeconomic status, patient preferences) which may have 
confounded some of the observed associations. Moreover, an important shortcoming of 
data from large population registries is the inability to grasp nuances, subtleties, or 
unrecorded factors which may affect individual patient care and management choices.  
For example, it is possible that our data may actually represent reasonable or even good 
patient care and patient’s choices.  
3.5 Conclusions 
 
The results of the present study demonstrate that the utilization of evidence- based 
medications and use of CABG or PCI in the setting of ACS has significantly increased 
over the period under study.  Despite these encouraging trends, important gaps in the use 
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of these treatment modalities persist in elderly patients and younger women. Given 
ongoing  demographic changes in economically developed and developing countries, 
resulting in more women and elderly patients seeking treatment for cardiovascular 
disease, the underlying reasons for differences in the use of effective treatment modalities 
by age and sex need to be more fully elucidated  to narrow current treatment disparities.  
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Medical School. Sanofi-aventis had no involvement in the collection, analysis, and 
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Table 3.1 Baseline Characteristics of Patients Hospitalized with an Acute Coronary Syndrome According to Age and Sex 
 Men  
P 
value 
Women  
P  
value 
 
Characteristic 
<65y 
(n=17302) 
65-74y 
(n=8504)  
75-84y 
(n=5890) 
≥  85y 
(n=1454) 
<65y 
(n=5254) 
65-74y 
(n=4414) 
75-84y 
(n=4880) 
≥  85y 
(n=2174) 
Age, mean( SD)†, yrs 53.8(7.6) 69.9(2.9) 79.3(2.8) 88.7(3.1)  54.8(7.6)  70.5(2.8) 79.7 (2.8) 89.2(3.4)  
Geographic region            
Australia/NewZealand/ 
Canada 
2197(12.7) 1161(13.7) 924(15.7) 195(13.4) <0.001 680(12.9) 571(12.9) 767(15.7) 269(12.4) <0.001 
 
Europe 8092(46.8) 4024(47.3) 2629(44.6) 549(37.8) <0.001 1997(38.0) 1935(44.3) 2100(43.0) 743(34.2) <0.001 
South America 3913(22.6) 1893(22.3) 1016(17.3) 166(11.4) <0.001 1416(27.0) 1015(23.0) 729(16.2) 299(13.8) <0.001 
US 3100(17.9) 1426(16.8) 1321(22.4) 544(37.4) <0.001 1161(22.1) 875(23.0) 1221(25.1) 867(39.7) <0.001 
Teaching hospital 1207(80.8) 5795(80.4) 3834(77.3) 859(69.8) <0.001 3499(81.5) 2848(80.8) 3013(76.2) 1293(70.3) <0.001 
Co-morbidity (n,%)           
Angina 8304(48.2) 4893(57.8) 3387(57.9) 775(53.7) <0.001 2936(56.1) 2576(58.6) 2668(54.8) 1007(46.7) <0.001 
Atrial fibrillation 489(2.9) 715(8.5) 895(15.4) 294(20.4) <0.001 132(2.5) 384(8.8) 673(14.0) 389(18.1) <0.001 
Diabetes 3325(19.3) 2387(28.2) 1565(26.7) 331(22.9) <0.001 1475(28.2) 1451(33.0) 1412(29.1) 456(21.1) <0.001 
Heart failure 772(4.5) 879(10.4) 928(16.0) 366(25.5) <0.001 369(7.1) 535(12.2) 907(18.7) 589(27.3) <0.001 
Hypertension 8704(50.6) 5354(63.4) 3882(66.4) 945(65.4) <0.001 3315(63.4) 3312(75.3) 3717(76.5) 1609(74.3) <0.001 
Kidney disease 764(4.4) 673(8.0) 807(13.8) 265(18.3) <0.001 304(5.8) 315(7.2) 481(9.9) 248(11.5) <0.001 
MI 4687(27.2) 2987(35.3) 2259(38.6) 620(42.9) <0.001 1299(24.9) 1251(28.5) 1487(30.6) 696(32.2) <0.001 
TIA/Stroke 705(4.1) 798(9.5) 806(13.8) 231(16.0) <0.001 323(6.2) 410(9.4) 619(12.8) 349(16.2) <0.001 
#Co-morbidity*           
0 4039(23.9) 988(12.0) 510(9.0) 99(7.0) <0.001 822(16.0) 386(9.0) 340(7.1) 169(8.0) <0.001 
1 5548(32.8) 2186(26.5) 1293(22.8) 308(21.8)  1478(28.7) 983(22.8) 1054(22.1) 494(23.3)  
93 
 
 
2 4647(27.5) 2665(32.3) 1755(30.9) 405(28.7)  1544(30.0) 1487(34.5) 1572(33.0) 612(28.9)  
≥ 3 2659(15.8) 2418(29.2) 2123(37.3) 593(42.5)  1299(25.3) 1453(33.7) 1797(37.8) 845(39.8)  
Current smoking 7756(46.0) 1726(20.9) 626(10.9) 77(5.5) <0.001 1891(36.9) 606(14.0) 324(6.8) 56(2.6) <0.001 
†SD: Standard deviation 
*Co-morbidities include angina/MI, atrial fibrillation, diabetes, heart failure, hypertension, kidney disease, TIA/Stroke  
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 Table 3.2 Clinical Presentation at the Time of Hospital Admission According to Age and Sex 
 Men P  
value 
Women P  
 <65y 65-74y 75-84y ≥  85y <65y 65-74y 75-84y ≥  85y value 
Pre-hospital 
Delay , min* 
160(84-365) 180(93-392) 180(95-392) 177(90-275) 0.17 180(95-420) 195(100-435) 191(100-442) 190(93-460) <0.001 
Systolic BP, 
mmHg 
139(120-156) 140(120-160) 140(120-160) 137(120-160) <0.001 140(120-160) 145(127-166) 144(125-165) 140(120-163) <0.001 
Diastolic BP, 
mmHg 
80(70-93) 80(70-89) 77(66-89) 74(63-85) <0.001 80(79-90) 80(70-90) 80(66-90) 74(60-87) <0.001 
Pulse, 
beats/min 
75(70-89) 75(63-92) 77(64-92) 80(66-96) <0.001 78(66-90) 78(67-91) 80(68-96) 84(70-100) <0.001 
Creatinine, 
mg/dl 
1.0(0.9-1.2) 1.1(0.9-1.5) 1.2(1.0-1.5) 1.4(1.1-1.7) <0.001 0.9(0.7-1.0) 0.9(0.8-1.1) 1.0(0.9-1.3) 1.1(0.9-1.5) <0.001 
Cholesterol, 
mg/dl 
195(165-228) 178(151-199) 169(140-199) 164(138-195) <0.001 198(166-234) 194(165-227) 190(160-223) 182(152-217) <0.001 
Triglycerides, 
mg/dl 
145(102-155) 123(87-144) 108(79-146) 94(69-128) <0.001 135(94-196) 127(92-178) 115(83-160) 103(74-146) <0.001 
Glucose, 
mg/dl 
120(102-155) 127(104-174) 130(106-174) 134(109-177) <0.001 122(100-169) 131(105-182) 130(106-178) 135(111-179) <0.001 
BMI,  kg/m2 27.5(24.9-30.6) 26.0(24.5-8.5) 26.0(23.8-8.5) 24.7(22.7-7.3) <0.001 27.5(24.2-32.0) 27.0(23.9-0.9) 25.8(23.0-29.3) 23.9(21.1-27.2) <0.001 
Killip class (n,%) 
      I 15459(91.0) 6904(83.1) 4308(75.0) 950(66.3) <0.001 4603(89.6) 3439(79.7) 3417(71.4) 1310(61.7) <0.001 
      II 1141(6.7) 1020(12.3) 1040(18.1) 339(23.7)  375(7.3) 645(15.0) 940(19.6) 538(25.3)  
      III 264(1.6) 300(3.6) 327(5.7) 120(8.4)  121(2.4) 191(4.4) 362(7.6) 234(11.0)  
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      IV 121(0.7) 84(1.0) 68(1.2) 23(1.6)  39(0.7) 40(0.9) 67(1.4) 43(2.0)  
Admission Diagnosis (n,%) 
STEMI  3914(44.3) 2854(33.6) 1833(31.1) 483(33.2) <0.001 1567(29.8) 1307(29.6) 1566(32.1) 775(35.7) <0.001 
NSTEMI/UA 4846(55.7) 5650(66.4) 4058(68.9) 971(66.8)  3687(70.2) 3107(70.4) 3305(67.9) 1399(64.3)  
STEMI: ST segment elevation MI; NSTEMI: Non ST segment elevation MI; UA: Unstable angina; BMI: Body mass index. 
*pre-hospital delay was defined as the duration of time from the onset of symptoms suggestive of ACS to hospital arrival; continuous variables:  medians 
and inter-quartiles ranges. 
96 
 
 
Table 3.3 Utilization of Cardiac Medications and Procedures in Eligible Patients during Hospitalization According to Age 
and Sex 
 
  ACE: Angiotensin converting enzyme; ARBs: Angiotensin II Receptor Blockers; CABG: coronary artery bypass graft; PCI: percutaneous coronary 
intervention 
 Men P 
values 
Women P  
values  <65y 65-74y 75-84y ≥  85y <65y 65-74y 75-84y ≥  85y 
Aspirin (n,%)  14785(96.7) 6491(96.1) 4088(95.1) 940(94.0) <0.001 4335(96.2) 3356(95.8) 3411(94.2) 1413(92.1) <0.001 
ACE inhibitors or ARBs (n,%) 10027(69.0) 5088(73.3) 3359(73.2) 724(67.0) <0.001 2935(67.9) 2625(73.6) 2875(73.7) 1096(68.7) <0.001 
Beta blockers (n,%)  11897(92.5) 4896(88.9) 2889(86.5) 592(86.6) <0.001 3503(89.7) 2491(87.3) 2409(86.8) 889(87.5) 0.003 
Statins (n,%)  12657(74.2) 5679(68.0) 3561(61.7) 699(50.0) <0.001 3600(69.5) 2825(65.2) 2835(59.6) 918(43.9) <0.001 
CABG (n,%)  910(5.3) 536(6.4) 281(4.8) 23(1.6) <0.001 257(5.0) 207(4.8) 147(3.1) 11(0.5) <0.001 
 PCI (n,%)  8514(49.6) 3458(41.0) 1920(32.8) 285(19.8) <0.001 1941(37.3) 1447(33.0) 1308(27.1) 299(13.9) <0.001 
CABG or PCI (n,%)  9286(54.4) 3951(47.0) 2176(37.3) 305(21.2) <0.001 2174(42.0) 1634(37.5) 1446(30.0) 309(14.5) <0.001 
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 Table 3.4 Odds Ratios (95% CIs) for the Utilization of Medications and Procedures in Eligible Patients Hospitalized with an 
Acute Coronary Syndrome According to Age and Sex 
 Men Women P P 
 <65y  65-74y 75-84y  ≥  85y  <65y 65-74y  75-84y  ≥  85y  value§ value† 
Aspirin           
      All patients  1.00 0.86(0.72-1.04) 0.84(0.68-1.03) 0.72(0.51-1.01) 0.80(0.65-0.99) 0.86(0.68-1.09) 0.68(0.55-0.84) 0.46(0.36-0.59) 0.27 0.57 
     NSTEMI/UA 1.00 0.88(0.70-1.11) 0.81(0.63-1.05) 0.67(0.45-1.00) 0.87(0.67-1.13) 0.86(0.64-1.14) 0.70(0.54-0.91) 0.48(0.35-0.66) 0.76 0.25 
      STEMI 1.00 0.82(0.60-1.13) 0.90(0.62-1.33) 0.84(0.44-1.61) 0.70(0.49-1.01) 0.91(0.58-1.43) 0.63(0.44-0.90) 0.40(0.27-0.61) 0.22 0.48 
ACE 
inhibitors/ARBs 
          
      All patients  1.00 1.09 (1.00-1.17) 1.01(0.93-1.11) 0.71(0.61-0.84) 0.83(0.76-0.91) 0.90(0.82-0.99) 0.89(0.81-0.98) 0.63(0.55-0.72) 0.81 0.20 
     NSTEMI/UA 1.00 1.09 (1.00-1.20) 1.05(0.95-1.17) 0.79(0.65-0.95) 0.81(0.73-90) 0.90(0.80-1.01) 0.92(0.82-1.03) 0.71(0.60-0.83) 0.76 0.31 
      STEMI 1.00 1.26 (1.09-1.45) 1.15(0.97-1.37) 0.68(0.51-0.90) 1.04(0.87-1.24) 1.09(0.89-1.33) 0.99(0.83-1.20) 0.59(0.47-0.75) 0.47 0.08 
Beta blockers           
      All patients  1.00 0.66(0.59-0.75) 0.52(0.45-0.60) 0.53(0.40-0.69) 0.67(0.58-0.78) 0.54(0.46-0.63) 0.53(0.45-0.62) 0.52(0.41-0.65) 0.003 0.80 
     NSTEMI/UA 1.00 0.66(0.57-0.77) 0.54(0.46-0.64) 0.68(0.49-0.95) 0.66(0.56-0.78) 0.52(0.44-0.62) 0.56(0.47-0.67) 0.55(0.42-0.73) 0.008 0.90 
      STEMI 1.00 0.76(0.59-0.99) 0.53(0.40-0.71) 0.30(0.19-0.50) 0.87(0.62-1.21) 0.79(0.54-1.15) 0.52(0.37-0.72) 0.48(0.30-0.76) 0.45 0.88 
Statins           
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      All patients 1.00 0.72(0.67-0.77) 0.49(0.45-0.54) 0.29(0.25-0.33) 0.82(0.75-0.90) 0.68(0.62-0.75) 0.44(0.40-0.48) 0.22(0.19-0.25) 0.06 0.67 
     NSTEMI/UA 1.00 0.74(0.68-0.81) 0.52(0.47-0.58) 0.31(0.26-0.37) 0.82(0.74-0.92) 0.72(0.64-0.80) 0.47(0.42-0.53) 0.24(0.21-0.27) 0.12 0.81 
      STEMI 1.00 0.70(0.62-0.80) 0.47(0.41-0.54) 0.26(0.20-0.33) 0.88(0.75-1.04) 0.65(0.55-0.77) 0.41(0.35-0.48) 0.20(0.16-0.24) 0.75 0.21 
CABG/ PCI           
      All patients  1.00 0.79(0.74-0.84) 0.53(0.49-0.57) 0.21(0.18-0.25) 0.64(0.59-0.70) 0.57(0.52-0.62) 0.38(0.35-0.42) 0.13(0.11-0.15) 0.12 0.46 
     NSTEMI/UA 1.00 0.82(0.75-0.89) 0.58(0.53-0.64) 0.21(0.17-0.26) 0.63(0.57-0.69) 0.58(0.52-0.64) 0.41(0.36-0.45) 0.13(0.10-0.16) 0.29 0.67 
      STEMI 1.00 0.82(0.73-0.92) 0.50(0.44-0.57) 0.22(0.17-0.28) 0.75(0.65-0.87) 0.62(0.53-0.72) 0.37(0.32-0.42) 0.13(0.11-0.17) 0.67 0.80 
≥3 medications           
      All patients 1.00 0.71(0.63-0.80) 0.60(0.52-0.69) 0.35(0.25-0.45) 0.76(0.67-0.86) 0.69(0.60-0.81) 0.58(0.50-0.67) 0.29(0.23-0.35) 0.046 0.42 
     NSTEMI/UA 1.00 0.72(0.63-0.83) 0.58(0.49-0.68) 0.37(0.27-0.50) 0.75(0.65-0.87) 0.71(0.59-0.84) 0.58(0.49-0.68) 0.29(0.23-0.37) 0.051 0.37 
      STEMI 1.00 0.75(0.60-0.94) 0.72(0.54-0.96) 0.34(0.21-0.56) 0.95(0.72-1.25) 0.79(0.57-1.09) 0.68(0.50-0.94) 0.32(0.21-0.46) 0.97 0.57 
STEMI: ST segment elevation MI; NSTEMI: Non ST segment elevation MI; UA: Unstable angina 
§ p values for interactions between age and sex 
† p values for 3-way interactions among age, sex, and study period 
Model 3 adjusted for study period (1999-2001, 2002-2003, 2004-2005, and 2006-2007), geographic region, type of hospital (teaching vs. others), history 
of heart failure, hypertension, or diabetes, and GRACE risk model factors: systolic blood pressure,  initial  serum creatinine, heart rate, cardiac enzyme, 
Killip class, ST-segment deviation, and  cardiac arrest at the time of hospital arrival.  
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Figure 3.1 Proportion of Patients Hospitalized with an Acute Coronary Syndrome Treated with 
≥3 Cardiac Medications according to Age and Sex by Study Period 
 
100 
 
 
 
 
Figure 3.2 Odd Ratios for the Utilization of ≥ 3 Cardiac Medications in Eligible Patients According to Age, Sex, and Study Period 
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Abstract 
Background 
Despite declines in in-hospital complications and short-term death rates in 
patients with acute myocardial infarction (AMI), several patient groups remain at 
increased risk for these adverse outcomes, including women and the elderly. However, 
recent trends in age and sex differences in short-term outcomes associated with AMI 
remain unexplored. The objectives of this study were to examine the overall magnitude, 
and changing trends, of age and sex differences in short-term outcomes in patients 
hospitalized with AMI. 
Methods  
The study population consisted of 13,663 residents of the Worcester, MA, 
metropolitan area hospitalized at all greater Worcester medical centers for AMI between 
1975 and 2005.  
Results 
In comparison with men <65 years, patients in various older age-sex strata  were 
significantly more likely to develop atrial fibrillation, cardiogenic shock, heart failure, 
and to die during hospitalization and in the first 30 days after admission. The odds of 
developing these hospital complications and dying increased with advancing age. There 
was a significant interaction between age and sex in relation to the development of 
several  of these outcomes; in patients <65 years, women were more likely to develop 
these complications and die compared with men, but in patients ≥ 65 years, there were no 
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significant sex differences. These age and sex differences have not changed significantly 
over time.  
Conclusions  
Younger women and the elderly were more likely to have adverse outcomes than 
younger men. More targeted treatment approaches during hospitalization for AMI for 
younger women and older patients are needed to improve their hospital prognosis.  
Word count: 249 
Key words: Acute myocardial infarction, hospital complications, hospital mortality, age 
and sex differences.   
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4.1 Introduction 
 
 
Over the past several decades, dramatic advances in the medical management of 
patients hospitalized with acute myocardial infarction (AMI) have been accompanied by 
reductions in in-hospital complications and short-term death rates. Despite encouraging 
declines in population death rates from coronary heart disease (CHD) in the U.S., and 
hospital mortality from AMI since the late 1960’s, several patient groups remain at 
increased risk for dying after AMI, including women and the elderly.  
Previous studies examining age and sex differences in the development of 
hospital complications and risk of dying in the setting of AMI have shown inconsistent 
results. 51,81,85,86,93-95  Some studies found that older persons and women had higher 
hospital complication and mortality rates compared to younger individuals and men, 
respectively. 51,91,93-95,118,119 On the other hand, several studies have failed to find any 
association between the risk of developing clinically significant hospital complications 
and/or dying between men and women of varying ages.81,85,86,120 Furthermore, there are a  
distinct lack of data from a broader community perspective that has examined changing, 
and contemporary,  associations between age/sex and short-term  hospital outcomes in 
patients hospitalized with AMI as well as the interaction between age and sex in relation 
to these endpoints.  Moreover, few  population-based studies have  examined whether  
differences in hospital outcomes  observed in prior studies according to age and sex have 
changed over time or whether important gaps in these endpoints continue to exist.91,121 
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The objectives of the present  study were to examine age and sex differences, and 
changing trends over an extended period (1975-2005), in important hospital 
complications as well as short-term (in-hospital and 30-day) mortality in patients 
hospitalized with AMI. Data from the population-based Worcester Heart Attack Study  
were utilized for this investigation.2,6,105,122 
4.2 Methods 
 
The Worcester Heart Attack Study is an ongoing population-based investigation 
that is examining long-term trends in the incidence, hospital, and post-discharge case-
fatality rates of AMI among residents of the Worcester metropolitan area (2000 census 
estimate = 478,000) hospitalized at all 16 greater Worcester medical centers in 15 
biennial periods between 1975 and 2005. 2,6,105,122  Fewer hospitals (n=11) have been 
included during recent study years due to hospital closures, mergers, and conversion to 
chronic care facilities.  The details of this study have been described previously.105,122  In 
brief, the medical records of patients hospitalized for possible AMI were individually 
reviewed and a diagnosis of AMI was validated according to predefined criteria.105,122 
Patients who developed AMI secondary to an interventional procedure or surgery were 
excluded from the study sample.  
Data Collection 
Information about demographic characteristics, medical history, clinical 
presentation, hospital treatment approaches, clinical complications, and hospital 
discharge status were abstracted from the hospital medical records of patients with 
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confirmed AMI by trained study physicians and nurses. Age was categorized into three 
strata, which was used previously in the literature, for purposes of analysis: <65 years, 
65-74 years, and ≥75 years. Development of hospital complications and short-term (in-
hospital and 30 day) mortality were the primary study outcomes. The criteria for atrial 
fibrillation included the documentation of atrial fibrillation in the physicians’ progress 
notes, based on the review of hospital medical records,  or occurrence of typical 
electrocardiographic changes consistent with a diagnosis of atrial fibrillation.100 Heart 
failure was considered to be present when there was clinical or radiographic evidence of 
pulmonary edema or bilateral basilar rales with an S3 gallop.101 Cardiogenic shock was  
defined as a systolic blood pressure of less than 80 mm Hg in the absence of hypovolemia 
and associated with cyanosis, cold extremities, changes in mental status, persistent 
oliguria, or congestive heart failure.102  The occurrence of acute stroke was  defined as 
the development of neurologic changes consistent with the presence of a stroke based on 
information contained in medical records and reviewed by  our  team of nurse and 
physician abstractors.99  Patients with a validated diagnosis of AMI discharged from all 
metropolitan Worcester hospitals were followed on an annual basis through the review of 
records for additional hospitalizations and search of death certificates at state and local 
Divisions of Vital Statistics. Some form of additional follow-up has been obtained for 
more than 99% of discharged hospital survivors from the cohorts included to date with 
follow-up completed through 2008. 
Candidate variables considered as potential confounders of the association 
between age/sex and the outcomes under study were chosen based on findings from prior 
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studies including study year, which was  grouped into 7 periods (1975/1978, 1981/1984, 
1986/1988, 1990/1993, 1995/1997, 1999/2001 and 2003/2005) for ease of analysis, race 
(white vs. non-white), marital status (single, married, divorced, widowed),  comorbidities 
(e.g., atrial fibrillation, diabetes, hypertension, stroke, heart failure), chest pain symptoms,  
AMI order (initial vs. prior), type (Q wave vs. non–Q wave) and location (anterior vs. 
other), and receipt of cardiac procedures during hospitalization (PCI, CABG), and length 
of stay.98  Information on pre-hospital delay was recorded beginning in 1986, information 
on  do not resuscitate (DNR) status was recorded beginning in 1991, data on body mass 
index (BMI) was collected beginning in 1995, and  information about whether the AMI 
was a non–ST-segment elevation myocardial infarction (NSTEMI) or an ST-segment 
elevation myocardial infarction (STEMI) was recorded beginning in 1997.  
Data Analysis 
Categorical data were summarized as percentages and were compared between 
patients of various age strata (<65, 65-74 and ≥75 years) and both sexes using the chi-
square test. Continuous variables were presented as medians (inter-quartile range, IQR) 
and were tested for possible differences according to age and sex using the Kruskal-
Wallis test.   
We examined the possible association between age/sex and various hospital 
outcomes using logistic regression models. Model 1 included age, sex, and study year. 
Model 2 further adjusted for race, marital status, and medical history of cardiovascular 
disease. Model 3 further adjusted for the presence of chest pain, AMI-associated 
characteristics, cardiac procedures, and length of stay.  This approach allowed us to 
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examine the contributions of various potentially confounding factors to observed age and 
sex differences in our principal study outcomes. To test whether any age or sex 
differences in our hospital endpoints have changed over time, 2-way and 3-way 
interaction terms between age, sex, and study year were created and included in each 
regression model. Likelihood ratio tests were used to test the nested models with and 
without interaction terms. A similar process was performed to examine the association 
between age/sex and 30-day mortality using Cox regression models. The proportional 
hazards assumption was checked graphically and satisfied. Further analyses in patients, 
who had information available on duration of pre-hospital delay after the onset of acute 
coronary symptoms, DNR status, and STEMI/NSTEMI, were also carried out in 
additional regression models. Random effect models were used to assess whether the 
different patient clusters within hospital affected our observed results. All analyses were 
performed using STATA 10.0. 
4.3 Results 
 
The study sample consisted of 13,663 residents of the Worcester metropolitan 
area hospitalized with validated AMI at all greater Worcester medical centers in 15 study 
years between 1975 and 2005. The average  age of this patient population, which was 
comprised of approximately three- fifths men, was 69 years; 36% of patients were <65 
years (75% men vs. 25% women), 26% were between the ages of  65- 74 years (59% 
men vs. 41% women), and 38% were ≥ 75 years (42% men vs. 58% women). Women 
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were considerably older than men at the time of hospital admission for AMI (means: 74 
years vs. 66 years).  
Baseline Characteristics 
Baseline characteristics of patients hospitalized with AMI according to age and 
sex are shown in Table 4.1. The proportion of patients with a history of atrial fibrillation, 
heart failure, hypertension, and stroke was higher in older patients in both sexes. Within 
the same age strata, women were more likely to have a previous history of hypertension, 
heart failure, and diabetes, but were less likely to have a history of atrial fibrillation, than 
men (Table 4.1). 
The proportion of patients with an initial and Q-wave MI was lower in older 
patients in both sexes (Table 4.1). The proportion of STEMI patients decreased with 
advancing age in men, but not in women. Within the same age strata, women were more 
likely to have an initial and anterior MI than men. Among patients <75 years, women 
were less likely to have a Q-wave MI than men, but in older patients these proportions 
were similar (34%). Among patients < 75 years, women were less likely to develop a 
STEMI than men, but among older patients, women were more likely to have a STEMI 
than men (Table 4.1). 
The proportion of patients reporting shortness of breath and fatigue was higher in 
older patients in both sexes (Table 4.1). Within the same age strata, women were more 
likely to report nausea and fatigue than men.  Among patients >65 years, women were 
less likely to report chest pain than men; however, among patients younger than 65 years, 
identical proportions of men and women reported chest pain (28%). The proportion of 
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patients with a DNR order in their hospital medical records was higher in older patients; 
within the same age strata, women were more likely to have a DNR order than men 
(Table 4.1). 
Heart rate and serum glucose levels were higher in older patients in both sexes; on 
the other hand, serum levels of cholesterol, LDL and triglycerides, GFR, and patient’s 
BMI were lower in older women and men (Table 4.1).  Within the same age strata, 
women were more likely to have a higher heart rate, serum cholesterol, triglycerides, and 
glucose levels, but lower diastolic blood pressure and GFR, than men. The proportions of 
patients undergoing angioplasty during hospitalization were lower in older patients in 
both sexes; within the same age groups, women were less likely to undergo coronary 
angioplasty and CABG during hospitalization (Table 4.1).  
Hospital Complications and Death According to Age and Sex  
Unadjusted Analyses 
Overall, older patients were more likely to have developed atrial fibrillation, 
cardiogenic shock, and heart failure than younger patients.  Within the same age groups, 
women were more likely to have developed heart failure and stroke than men (Table 4.2). 
Hospital and 30-day case-fatality rates were higher in older patients; within the same age 
strata, women were more likely to have died during hospitalization or during the first 30 
days after hospital admission than men (Table 4.2). 
In examining trends in hospital mortality according to age and sex, declining 
trends in hospital mortality were observed for all groups (Figure 4.1). Between 
1975/1978 and 2003/2005, the greatest absolute decline in hospital mortality was 
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observed in women ≥ 75 years (43% vs. 13%), followed by men 75 years and older (31% 
vs. 13%), men 65-74 years (23% vs. 8%), women 65-74 years (26% vs. 12%), women < 
65 years (14% vs. 5%), and men <65 years (9% vs. 2%).   
Multivariable Adjusted Analyses 
Hospital Complications  
For atrial fibrillation, the overall odds of developing this complication increased 
with advancing age in both men and women (Table 4.3).   Compared with men < 65 years, 
other age- sex groups  were significantly more likely to develop atrial fibrillation in all 3 
regression models with the exception of women <65 years. There was no evidence of an 
interaction between age and sex in relation to the development of this arrhythmia. The 
non- significant 2-way and 3-way interactions among age, sex, and study year indicated 
that age and sex differences in the risk of developing atrial fibrillation in patients 
hospitalized with AMI have been relatively unchanged over time (Table 4.3, Figure 4.2).  
For heart failure, the overall odds of developing this clinical syndrome increased 
with advancing age in both men and women (Table 4.3).   Compared with men < 65 years, 
other age- sex groups were significantly more likely to have developed heart failure in all 
3 regression models. There were significant interactions between age and sex in relation 
to the development of heart failure in our unadjusted model and in the model adjusted for 
marital status and medical history (Model 1, 2, Table 4.3); however, the interaction 
between age and sex became non-significant when the regression model was further 
adjusted for clinical presentation, cardiac procedures, and length of hospital stay (Model 
3, Table 4.3). The non- significant 2-way and 3-way interactions among age, sex, and 
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study year indicated that age and sex differences in heart failure have been relatively 
unchanged over time (Table 4.3, Figure 4.3). 
For cardiogenic shock, the overall odds of developing this complication increased 
with advancing age in men but not in women (Table 4.3). Compared with men < 65 years, 
other age and sex groups were significantly more likely to have developed cardiogenic 
shock in all 3 regression models.  There were significant interactions between age and 
sex in relation to the development of cardiogenic shock; in patients <65 years, women 
were more likely to have developed cardiogenic shock compared with men (Adjusted OR: 
1.77, 97% CI: 1.31-2.41, model 3), but in patients ≥ 65 years, there was no significant 
difference between men and women in the risk of developing cardiogenic shock (Table 
4.3). The non- significant 2-way and 3-way interactions among age, sex, and study year 
indicated that age and sex differences in cardiogenic shock have been relatively 
unchanged over time (Table 4.3, Figure 4.4).  
Due to the small number of acute stroke events, no multivariable regression 
analysis was performed for this study outcome. 
Short-Term Mortality 
Overall, the odds of dying during hospitalization, and the risk of dying during the 
first 30 days after admission, increased with advancing age in both men and women 
(Table 4.3).  Compared with men < 65 years, other age and sex groups experienced 
significantly higher short-term death rates in all 3 regression models. There was a 
significant interaction between age and sex in relation to short-term mortality; among 
patients <65 years, women had significantly higher in-hospital mortality (Adjusted OR: 
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1.62, 97% CI: 1.23-2.14, model 3) and 30-day mortality compared to men (Adjusted HR: 
1.72, 97% CI: 1.32-2.24, model 3); however, among patients ≥ 65 years, there were no 
significant differences in the risk of short-term mortality between men and women (Table 
4.3). The non- significant 2-way and 3-way interactions among age, sex, and study year 
indicated that age and sex differences in short-term (in-hospital and 30-day) mortality 
have been relatively unchanged over time (Table 4.3, Figure 4.5). 
Further regression analyses performed in patients who had information available 
on pre-hospital delay, DNR status, and STEMI/NSTEMI provided relatively similar 
results. Random effect models assessing the effects of patient clusters within hospital 
provided similar results and did not change our conclusions.  
4.4 Discussions  
 
In this study of more than 13,000 residents of a large central New England 
metropolitan area hospitalized with AMI, we found that, compared with men <65 years, 
older men and women were more likely to develop atrial fibrillation, cardiogenic shock, 
and heart failure, and were more likely to have died during hospitalization and in the first 
30 days after admission, for AMI. There was a  significant interaction between age and 
sex in relation to the  development of these important  hospital complications and death; 
in patients <65 years, women were more likely to develop these complications and to die 
compared with men, but in patients ≥ 65 years, there were no significant differences 
between men and women in the occurrence of these outcomes. These age and sex 
differences have not changed significantly over the past 3 decades. 
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Our results are consistent with the findings from previous studies51,91,93 which 
have shown that older persons were significantly more likely to develop clinically 
significant  complications and to die than younger individuals in patients hospitalized 
with AMI  and age was a more important predictor of poor hospital prognosis than sex. 
For example, a retrospective cohort study that included more than 17,000 patients in the 
Analysis of Delay in AMI register (ARIAM) in 119 Spanish hospitals between 1995 and 
2001, found that the risk of developing  various  hospital complications, including heart 
failure, shock, and stroke, and dying  increased significantly with advancing age.51 Older 
patients are  more likely to have additional comorbidities present,  including diabetes, 
hypertension, and heart failure,20,39,52 at the time of their AMI  which may increase their 
risk of adverse outcomes. In addition, previous studies have shown that older patients 
were less likely to be treated with effective medications and cardiac procedures51,113 that 
may have  contributed to their  higher risk  of hospital complications and dying. Other 
factors such as prolonged delay in seeking medical care,8-10 limited health care access, 
cognitive impairment, and frailty may have contributed to the adverse outcomes noted in 
older persons. 
Sex differences in hospital complications and short-term mortality were found in 
our study in patients < 65 years, but not in patients ≥65 years, a finding which is 
consistent with the results of previous studies. 94,103,117,119,123,124  For example, findings 
from the Swedish National Acute Myocardial Infarction of  approximately 350,000 
patients aged 30 to 89 years over the period 1987-1995 demonstrated  higher  early 
mortality rates in women than men but only in patients <70 years.123  Similarly, a recent 
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publication from the National Registry of Myocardial Infarction (NRMI), that included 
approximately 360,000 patients from 2000 and 2006, found that in patients  <70 years, 
women had a  higher hospital death  rate than men; in older patients, however,  women 
had either a similar (among STEMI patients) or lower hospital death rate (among 
NSTEMI patients) compared with men.103         
 The reasons for worse short-term outcomes in younger women hospitalized with 
AMI are unclear. This may be partially explained by the fact that women are  more likely 
to have additional comorbidities present, such as diabetes and heart failure, than men, and 
differences  in these and other important prognostic factors are likely to be  more 
pronounced in younger than in older individuals.123  In addition, young women have been 
shown to be  less likely to be treated with effective medications117,121 compared with  
young men, which can contribute to the  worse outcomes noted  in younger women. 
However, a previous analysis in approximately 380,000 patients included in   the NRMI 
suggested that the differences in medical history, clinical severity of the infarction, and 
early management accounted only for about one third of the differences in early mortality 
observed  between men and women.94 Moreover, in the present study, we found that 
women were more likely to develop clinical complications than men in younger patients 
only, while there was no sex difference in the frequency of these complications in older 
patients, which could explain the excess mortality observed in younger women than men. 
The fact that men may be  more likely to die out-of-hospital from coronary disease  than 
women, and that this sex  difference may be  larger in younger than in older patients,123 
could contribute to higher in-hospital mortality rates in younger women hospitalized with 
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AMI compared with men.  More studies need to be done to further understand the reasons 
behind the greater risk of adverse outcomes noted in younger women hospitalized with 
AMI.    
In examining whether age and sex differences in various short-term outcomes 
have changed over time, our results suggest that age and sex differences in hospital 
complications and deaths have not changed significantly over time with the exception of 
cardiogenic shock. On the other hand, a recent publication from the NRMI that included 
approximately 910,000 patients with AMI between 1994 and 2006 demonstrated that  sex 
differences in  hospital mortality have narrowed over time.121 Differences between these 
studies may be due to the characteristics of the respective study samples, 
inclusion/exclusion criteria, sample size, and periods under study.   
Our findings showed that although hospital mortality associated with AMI has 
decreased over time (21% in 1975/1978 vs. 9% in 2003/2005), age and sex differences in 
important clinical complications and mortality have not changed significantly over time; 
younger women and the elderly are still at higher risk for these adverse outcomes than 
younger men. Inasmuch, greater use of prevention programs and effective cardiac 
treatment regimens for younger women and the elderly are needed to improve their short-
term outcomes.     
Study Strengths and Limitations  
This study has several strengths including its population-based design that 
captured all validated cases of AMI occurring among unselected residents  of the 
Worcester metropolitan area hospitalized at all Central Massachusetts  medical centers  
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over a 30 year period. However, several limitations need to be kept in mind in 
interpreting the present findings. First, the majority of the study population was white; 
therefore, the generalizability of our findings to other race/ethnic groups is limited. We 
did not have information available on several patient associated characteristics (e.g., 
socioeconomic status, psychological factors) which may have confounded some of the 
observed associations. Finally, since patients who died out of the hospital from AMI were 
not included, the findings only apply to patients hospitalized with AMI; the direction and 
magnitude of the associations between age/sex and these outcomes in patients who died 
before reaching the hospital may be different from those who are hospitalized.            
 
4.5 Conclusions 
 
Our results suggest that younger women and the elderly were more likely to 
experience adverse short-term outcomes in the setting of AMI compared with younger 
men and these differences have relatively unchanged over time. Future studies should 
focus on investigating the reasons for these differences in order to optimize the treatment 
of these high risk groups and improve their short-term prognosis.   
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Table 4.1. Baseline Characteristics of  Patients with Acute Myocardial Infarction (AMI) According to Age and Sex 
 Men 
P-value 
Women 
P-value Characteristics 
<65 y 
(n=3,657) 
65-74y 
(n=2,103) 
≥ 75y 
( n=2,205) 
<65y 
(n=1,202) 
65-74y 
(n=1,453) 
≥ 75y 
(n=3,004) 
Mean age ± SD, years 53.4±8.5 69.6±2.9 81.6±5.1   55.0±8.8 70.0±2.8 83.0±5.6   
White, n (%) 3,294(93.5) 1,926(95.4) 2,090(97.6) <0.001 1,073(92.0) 1,315(94.6) 2,822(96.8) <0.001 
Marital status, n (%)                 
      Single 436(12.1)  202(9.7)  163(7.5)   <0.001  136(11.6)  139(9.7) 325(11.1)  <0.001 
      Married  2,798(77.4)  1,598(77.1)  1,435(66.1)    727(61.8)  654(45.8)  723(24.6)   
      Divorced  198(8.3)  107(5.2)  58(2.7)    158(13.4)  94(6.6)  78(2.7)   
      Widowed  81(2.2)  166(8.0)  514(23.7)    156(13.2)  540(37.8)  1,814(61.6)   
Medical History, n (%)                
      Atrial fibrillation 56(2.7) 140(11.2) 312(19.7) <0.001 17(2.4) 77(8.8) 377(17.5) 
  
<0.001 
      Hypertension 1,668(45.6)  1,163(55.3) 1,315(59.6) <0.001  647(53.9)  984(67.7)  2,074(69.1)  <0.001  
      Heart failure 217(5.9) 337(16.0) 622(28.2) <0.001 144(12.0) 308(21.2) 971(32.3) <0.001 
      Diabetes 703(19.2) 637(30.3) 639(29.0) <0.001 401(33.4) 560(38.5) 887(29.5) <0.001 
      Stroke 134(3.7) 216(10.3) 349(15.8) <0.001 78(6.5) 159(10.9) 394(13.1) <0.001 
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      CABG 112(3.1) 131(6.2) 217(9.8) <0.001 53(4.4) 68(4.7) 106(3.5) 0.135 
AMI characteristics, n (%)         
      Initial 2,627(72.1) 1,252(59.7) 1,275(58.0) <0.001 879(73.3) 953(65.7) 1,883(62.8) <0.001 
      Q-wave 1,889(55.4) 857(44.1) 662(33.5) <0.001 517(46.7) 542(40.0) 917(34.3) <0.001 
      Anterior 1,129(33.2) 717(36.8) 653(33.1) 0.015 416(37.7) 528(38.9) 953(35.8) 0.128 
      STEMI* 664(18.2) 301(14.3) 289(13.1) <0.001 209(17.4) 169(11.6) 437(14.6) <0.001 
Clinical symptoms, n (%)         
      Chest pain 1,018(28.0) 495(23.8) 627(29.1) <0.001 333(28.1) 294(20.6) 724(24.7) <0.001 
      Shortness of breath 673(18.4) 404(19.2) 616(27.9) <0.001 253(21.1) 310(21.3) 858(28.6) <0.001 
      Nausea 480(13.1) 198(9.4) 235(10.7) <0.001 203(16.9) 168(11.6) 407(13.6) <0.001 
      Diaphoresis 661(18.1) 267(12.7) 320(14.5) <0.001 196(16.3) 192(13.2) 394(13.1) 0.019 
      Fatigue 142(3.9) 95(4.5) 182(8.3) <0.001 55(4.6) 88(6.1) 348(11.6) <0.001 
DNR order, n (%)* 53(2.8) 122(11.2) 472(33.1) <0.001 47(7.4) 113(15.5) 900(45.7) <0.001 
Pre-hospital delay (hour)*, median 
(IQR)  1.9(1.0- 4.1) 2.0(1- 4.5) 2.5(1.2-5.1)  <0.001 2.0(1.0-4.7) 2.4(1.3-5.5) 2.3(1.2-5.0)  0.018 
Clinical parameters on admission, median (IQR)  
 Heart rate(beats/min) 80(67-94) 81( 67-100) 87(71-102) <0.001  83(70-99) 84(72-102) 88(74-105) <0.001  
 Systolic BP, mmHg 141(122-161.5) 142(121-160) 140(117-160)  0.051 142(121-164) 143(120-170) 141(120-165)  0.82 
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IQR: Inter quartile range; LDL, low-density lipoprotein; GFR, glomerular filtration rate; PCI: Percutaneous coronary intervention; CABG: Coronary 
Artery Bypass Graft 
 *Information on pre-hospital delay, DNR status, BMI and STEMI was recorded beginning in 1986, 1991, 1995 and 1997, respectively.  
 
 Diastolic BP, mmHg 84(70-98) 80(67-91) 73.5(61-86)  <0.001 80(64-92) 77(64-90) 70(57.5-86) <0.001  
 BMI(kg/m2)* 28.6(25.7-32.3) 27.3(24.4-30.3) 25.6(23.1-28.0) <0.001  28.1(24.5-33.1) 27.3(23.0-32.1) 24.6(21.3-28.3)  <0.001 
Laboratory findings on admission, median (IQR)  
 Cholesterol(mg/dl) 210(178-246) 192(162-230) 177.5(147-214)  <0.001 220(181-259) 221(183-260) 204(166-240)  <0.001 
 LDL(mg/dl) 115(94-142) 105(82-124) 97(75-121) <0.001  111(87-142) 107(84-141) 102(78-133) <0.004  
 Triglyceride(mg/dl) 134(95-194) 115(85-177) 98(67-136)  <0.001 139(93-197) 129(94-198) 105(76-152) <0.001  
 Glucose(mg/dl) 134(112-178) 151(119-209) 150(120-209) <0.001  146(116-238) 163(125-247) 161(126-228) 0.024  
 GFR 80(66-92) 64(49-79) 52(37-68) <0.001  69(50-83) 58(43-67) 46(33-62)  <0.001 
In-hospital Procedures, n (%)         
     PCI 812(22.2) 308(14.7) 235(10.7) <0.001 235(19.6) 196(13.5) 268(8.9) <0.001 
     CABG 147(4.0) 107(5.1) 69(3.1) <0.001 44(3.7) 61(4.2) 47(1.6) <0.001 
Length of stay (day), median (IQR) 8(4-13) 8(5-14) 7(4-12) <0.001  8(4-14) 9(5-14) 7(4-11)  <0.001 
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† Information on the occurrence of stroke was recorded beginning in 1986.  
Table 4.2 Overall Hospital Complication and Death Rates in Patients with Acute Myocardial Infarction According to Age and Sex 
Complications, n(%) 
Men 
P-value 
Women 
P value 
<65y 65-74y ≥ 75y <65y 65-74y ≥ 75y 
Atrial fibrillation 300(8.2) 391(18.6) 578(26.2) <0.001 104(8.7) 228(15.7) 739(24.6) <0.001 
Heart failure 807(22.1) 838(39.9) 1,110(50.3) <0.001 370(30.8) 633(43.6) 1,633(54.4) <0.001 
Cardiogenic shock 159(4.4) 149(7.1) 174(7.9) <0.001 81(6.7) 109(7.5) 232(7.7) 0.55 
Stroke† 6(0.3) 5(0.4) 13(0.8) <0.001 2(0.3) 11(1.1) 21(1.0) <0.001 
In-hospital mortality 201(5.5) 285(13.6) 462(21.0) <0.001 102(8.5) 221(15.2) 676(22.5) <0.001 
30-day mortality from admission 426(11.7) 417(19.8) 694(31.5) <0.001 188(15.6) 298(20.5) 1,007(33.5) <0.001 
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Table 4.3 Overall Age and Sex Differences in Short-Term Outcomes in Patients with Acute Myocardial Infarction 
 
 Men Women P 
values† 
P 
values‡  <65y 65-74y ≥ 75y <65y 65-74y ≥ 75y 
Hospital 
Complications 
Odd Ratios (95%CI) 
Atrial Fibrillation         
Model 1 1.00 2.56(2.18-3.01) 3.93(3.37-4.57) 1.07(0.85-1.35) 2.09(1.73-2.51) 3.16(3.12-4.17) 0.19 0.27 
Model 2 1.00 2.46(2.09-2.91) 3.52(3.00-4.14) 1.02(0.80-1.29) 1.98(1.54-2.32) 2.98(2.52-3.53) 0.17 0.28 
Model 3 1.00 2.37(1.98-2.84) 3.49(2.93-4.17) 1.02(0.79-1.32) 1.79(1.47-2.25) 2.98(2.47-3.58) 0.18 0.31 
Heart Failure         
Model 1 1.00 2.37(2.10-2.67) 3.82(3.40-4.29) 1.60(1.38-1.85) 2.87(2.43-3.15) 4.49(4.03-5.00) 0.002 0.52 
Model 2 1.00 1.98(1.76-2.26) 2.75(2.42-3.11) 1.33(1.14-1.56) 1.97(1.70-2.28) 2.86(2.51-3.26) 0.013 0.61 
Model 3 1.00 1.84(1.61-2.11) 2.49(2.17-2.86) 1.31(1.11-1.54) 1.87(1.60-2.19) 2.67(2.30-3.07) 0.07 0.26 
Cardiogenic Shock         
Model 1 1.00 1.69(1.34-2.13) 1.99(1.59-2.48) 1.59(1.20-2.09) 1.80(1.40-2.31) 1.94(1.57-2.39) 0.020 0.22 
Model 2 1.00 1.63(1.28-2.06) 1.88(1.48-2.38) 1.51(1.13-2.01) 1.66(1.26-2.18) 1.75(1.37-2.25) 0.029 0.09 
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Model 3 1.00 1.83(1.41-2.37) 2.57(1.98-3.32) 1.77(1.31-2.41) 2.11(1.57-2.82) 2.42(1.85-3.18) 0.006 0.35 
Hospital Mortality         
Model 1 1.00 2.80(2.32-3.39) 5.47(2.57-6.53) 1.63(1.27-2.09) 3.25(2.65-3.98) 5.97(5.04-7.07) 0.023 0.36 
Model 2 1.00 2.62(2.16-3.19) 4.83(4.00-5.84) 1.57(1.21-2.03) 2.84(2.29-3.53) 5.02(4.13-6.10) 0.022 0.37 
Model 3 1.00 2.67(2.16-3.30) 5.46(4.46-6.70) 1.62(1.23-2.14) 3.08(2.44-3.90) 5.56(4.50-6.87) 0.018 0.56 
30-day mortality  Hazard Ratios (95%CI) 
Model 1 1.00 2.87(2.39-3.45) 5.37(4.53-6.36) 1.67(1.31-2.13) 2.96(2.42-3.62) 5.76(4.90-6.77) 0.004 0.84 
Model 2 1.00 2.64(2.19-3.20) 4.53(3.79-5.14) 1.57(1.22-2.01) 2.49(2.01-3.07) 4.53(3.77-5.44) 0.003 0.94 
Model 3 1.00 2.85(2.34-3.47) 5.28(4.38-6.37) 1.72(1.32-2.24) 2.91(2.34-3.65) 5.29(4.36-6.42) 0.016 0.99 
         
 
† p values for interaction between age and sex 
‡ p values for 3-way interaction among age, sex, and study period 
Model 1: Included age, sex, and interaction between age, sex, and study period 
Model 2: Further adjusted for marital status and medical history of hypertension, diabetes, CABG, stroke, and heart failure 
Model 3: Further adjusted for chest pain and AMI characteristics (Q wave vs. non-Q wave; initial AMI vs. recurrent AMI, 
anterior AMI vs. non-anterior AMI), cardiac procedures, and length of stay. 
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Figure 4. 1 Hospital Case- Fatality Rates According to Age, Sex, and Study Period 
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Figure 4.2 Adjusted Odds Ratios of  Developing Atrial Fibrillation According to Age, Sex, and Study Period 
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Figure 4.3 Adjusted Odds Ratios of  Developing Heart Failure According to Age, Sex, and Study Period  
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Figure 4.4 Adjusted Odds Ratios of  Developing Cardiogenic Shock According to Age, Sex, and Study Period  
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 Figure 4.5 Adjusted Odds Ratios of In-Hospital Mortality According to Age, Sex, and Study Period 
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 CHAPTER V 
Conclusions 
 
5.1 Summary of Findings 
  
The objectives of this dissertation were to examine age and sex differences, and 
changing trends therein, in duration of pre-hospital delay, hospital management practices, 
and short-term outcomes in patients hospitalized with an ACS/AMI.   
In examining changing trends in duration of pre-hospital delay in nearly 6,000 
residents of a large central New England metropolitan area hospitalized with AMI 
between 1986 and 2005 (chapter II), we found that in overall patient’s care seeking 
behavior after the onset of acute coronary symptoms has been relatively unchanged over 
the past 2 decades. In examining the association between age/sex and duration of pre-
hospital delay, as compared with younger men, other age/sex groups were significantly 
more likely to delay seeking medical care after the onset of symptoms suggestive of AMI, 
with the exception of women < 65 years. There was an interaction between age and sex in 
relation to duration of pre-hospital delay.  These age and sex differences have narrowed 
over time which has been largely explained by changes in patient’s comorbidity profile 
and AMI associated characteristics.  
In examining changing trends in the use of evidence-based medications in more 
than 50,000 patients hospitalized with an ACS between 1999 and 2007 in the large 
multinational GRACE study (chapter III), we found a marked increase in the hospital use 
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of several key evidence-based cardiac medications, CABG surgery, and PCI in men and 
women of various age strata.  In comparison with men <65 years, patients in other age-
sex strata were less likely to be treated with these medications and cardiac procedures. 
There was some evidence, however, which suggested that there were interactions 
between age and sex with the use of beta blockers and multiple medications in that 
younger women were less likely to be treated with these medications during 
hospitalization for an ACS compared with younger men. Despite encouraging increases 
in prescribing practices over time, age and sex differences with regards to the prescribing 
of most effective cardiac therapies have not changed significantly during the period under 
study with the exception of beta blockers. 
In examining changing trends in short-term outcomes in more than 13,000 
residents of a large central New England metropolitan area hospitalized with AMI 
between 1975 and 2005 (chapter IV), we found  declines  in the frequency of important 
hospital complications, and increases in short-term  survival, for all patients. In 
comparison  with men <65 years, older men and women were more likely to develop 
atrial fibrillation, cardiogenic shock, and heart failure, and were more likely to have died 
during hospitalization and in the first 30 days after admission. There was a significant 
interaction between age and sex in relation to the development of these important hospital 
complications and death; in patients <65 years, women were more likely to develop these 
complications and to die compared with men; on the other hand, in patients ≥ 65 years, 
there were no significant differences between men and women in the occurrence of these 
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outcomes. These age and sex differences have not changed significantly over the past 3 
decades. 
These findings suggest that the elderly were more likely to experience longer pre-
hospital delay, were less likely to be treated with evidence-based treatments during 
hospitalization for acute coronary disease, and were more likely to develop adverse 
outcomes compared to younger persons. Younger women were less likely to be treated 
with effective treatments and were more likely to develop adverse outcomes compared 
with younger men. That may be partially explained by the differences in clinical 
presentation, coping mechanism when having symptoms suggestive of ACS/AMI, 
medical history, medical management practices between older and younger patients, and 
between men and women at younger age. Thus, more studies are needed to fully 
understand the reasons of these differences in order to design effective interventions 
aiming at narrowing these gaps. The elderly and younger women with ACS/AMI should 
receive more intentions with regards to both prevention and treatment to improve these 
outcomes. 
 
5.2  Strengths and Limitations 
 
 
A particular strength of the dissertation was the use of data from two large 
population-based and multinational registries of patients with ACS/AMI, which provide 
long-term and contemporary data on patients hospitalized with an ACS/AMI. On the 
other hand, as with all observational studies, the WHAS and the GRACE project are 
subject to certain inherent limitations and potential biases.   
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This WHAS has several strengths including its population-based design that 
captured all validated cases of AMI occurring among unselected residents  of the 
Worcester metropolitan area hospitalized at all Central Massachusetts  medical centers  
over a 30 year period. However, several limitations need to be kept in mind in the 
findings of this community-wide investigation. First, a considerable proportion of 
patients had data missing on pre-hospital delay; therefore, our findings should be 
interpreted with caution. Second, information about pre-hospital delay was abstracted 
from hospital medical records whose documentation may have varied over time and 
according to patient’s demographic characteristics.  In addition, the majority of the study 
population was White; therefore, the generalizability of our findings may be limited.  We 
did not have information available on several patient associated characteristics (e.g., 
socioeconomic status) which may have confounded some of the observed associations, 
nor did we have information on the reasons why patients delayed seeking medical care.  
Finally, since patients who died out of the hospital from AMI were not included, the 
findings may only apply to patients hospitalized with AMI. 
The GRACE study is the largest multinational registry to include the complete 
spectrum of patients hospitalized with an ACS. Standardized criteria are employed for 
defining ACS and hospital outcomes and rigorous quality control and audit measures are 
employed. ”Real-life” observational studies such as GRACE provide data on a 
heterogeneous population of patients that includes groups who are often under-
represented in randomized trials, including  women and  the elderly.8 On the other hand, 
as an observational study, GRACE is subject to certain inherent limitations and potential 
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biases that must be kept in mind in interpreting the study results. Treatments were given 
according to individual physicians’ decisions and not through the use of standardized 
treatment protocols. While currently recommended criteria were utilized to characterize 
patients who were eligible for the receipt of the cardiac medications examined, due to our 
reliance on data obtained from medical records, questions might be raised about our 
ability to characterize patient’s eligibility status. Furthermore, we did not have 
information available on several patient associated characteristics (e.g., socioeconomic 
status, patient preferences) which may have confounded some of the observed 
associations. 
5.3 Implications and Future Research Directions 
 
Our results reinforce the need for the development of intervention programs to 
educate patients about the importance of seeking medical care promptly after the onset of 
symptoms suggestive of AMI since the prompt seeking of medical care is associated with 
the receipt of coronary reperfusion therapy and is crucial to reducing mortality and the 
risk of serious clinical complications in these patients. Moreover, since older men and 
women were at greatest risk for prolonged delay, interventions designed to reduce pre-
hospital delay might be primarily focused on older men and women. Further qualitative 
studies might also be carried out in older men and women to identify the reasons why 
these high risk groups fail to react promptly to their symptoms of acute coronary disease 
focusing on their levels of cognition, knowledge, and attitudes toward health care.  
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In examining changing trends in the utilization of evidence -based medications 
and interventional procedures, our results suggest that age and sex gaps in the utilization 
of most medications have not changed significantly over time with the exception of beta 
blockers and the use of multiple medications.  These findings suggest the need for greater 
understanding of the reasons underlying these treatment disparities and for the 
development of educational interventions and targeted programs to enhance the more 
optimal treatment of these high risk patients. Educational campaigns should continue to 
target older patients and younger women with respect to the receipt of effective cardiac 
treatments in the setting of an ACS since contemporary gaps in their more optimal 
management continue to remain.  
Our findings showed that although hospital mortality associated with AMI has 
decreased over time, age and sex differences in important clinical complications and 
mortality have not changed significantly; younger women and the elderly are still at 
higher risk for these adverse outcomes than younger men. More studies need to be done 
to further understand the reasons behind the greater risk of adverse outcomes noted in 
younger women hospitalized with acute coronary diseases.  Inasmuch, greater use of 
prevention programs and effective cardiac treatment regimens for younger women and 
the elderly are needed to improve their short-term outcomes.     
In conclusion, the findings of this dissertation provide useful and contemporary 
information regarding age and sex differences in patients hospitalized with an ACS/AMI 
with regards to duration of pre-hospital delay, hospital management practices, and short-
term outcomes. These data can inform the design of appropriate public health 
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interventions and clinical guidelines to improve the short as well as long-term outcomes 
of all persons hospitalized with ACS/AMI. 
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